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Abstract 
 
Insects are confronted by a large variety of potentially harmful microorganisms to which they 
are resistant as they are able to build up an efficient innate defense system that relies on three 
tightly interconnected reactions. One of the reactions is the transient and rapid synthesis of a 
battery of antimicrobial peptides (AMPs). Development of antimicrobial therapeutic drugs 
and vaccines is very crucial due to factors such as the emergence of multiple-drug resistance. 
AMPs have been termed natural antibiotics because of their large spectrum of activity. The 
current study focused on the isolation and identification of cationic antimicrobial peptides 
and the analysis of immune response in the South African Euoniticellus intermedius 
embryonic (SAEIE08) cell line upon exposure to pathogens. E. intermedius is of the 
Coleopteran order in the Scarabaeoidea superfamily. Liquid growth inhibition assay showed 
higher antimicrobial activity in SAEIE08 that was treated with heat-killed E. coli compared 
to untreated. Further evidence for antimicrobial activity was seen as a clear zone of inhibition 
in solid growth inhibition assay when a gel run with protein extracts was plated and 
overlayed with live E. coli. Changes in protein expression patterns that were analysed in 
SDS-PAGE and 2-D PAGE indicated the most intense bands and spots at low molecular 
weight sizes around 10 kDa and/or 16 kDa which implicated increased induction of AMP 
expression upon exposure to pathogen. Homologues of Saccharomyces cerevisiae proteins 
were found in some of the 5′/3′ RACE sequences. Possible explanation for matches to these 
homologues could be that short sequences were used for database searches. The proteins were 
identified as flavin-containing monooxygenase, long-chain fatty acyl-CoA synthetase, severe 
depolymerization of actin protein and serine/threonine protein kinase. Interestingly, these 
proteins play roles in metabolism, cell proliferation and/or molecular pathways which do 
occur when cells are exposed to stress. There was also an insect peptide allatotropin from 
Spodoptera frugiperda. The results show that there is inducible antimicrobial activity in 
embryonic E. intermedius cell line.  
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Chapter 1: Introduction 
 
1.1. Insect Immunity 
 
Insects colonize all ecological niches excluding the Polar Regions and the deep marine 
environment (Bulet, et al. 1999). In terms of species number, insects represent the largest 
class in the animal kingdom (Li, et al. 2012). The ability of insects to resist pathogens has 
contributed significantly to their extreme diversity (Bulet, et al. 1999). Insects are confronted 
by a very large variety of microorganisms that are potentially harmful. Like most living 
organisms, they are continually exposed to potentially harmful organisms through contact, 
inhalation and ingestion (Reddy, et al. 2004). Insects can build up efficient defense against 
microorganisms and they resist microbial infections in particular. Their defense mechanisms 
share some important characteristics with the innate immune response of vertebrates. It is 
innate non-adaptive and lacks both specificity and memory (Hoffmann, 1995). Over the last 
10 years, a number of studies have revealed similarities between pathogen recognition, 
effector mechanisms and signalling pathways of innate immunity in invertebrates and 
vertebrates, which indicates common ancestry between these defenses (Girard, et al. 2007). 
Although humans and insects share innate immunity, they differ in that humans also have 
adaptive immunity. Some of the conserved molecular signalling pathways that are used by 
humans and insects to fight pathogenic attack are also used for early development of the 
embryo in insects (Ntwasa, et al. 2012).  
 
E. Metchnikow in St. Petersburg initiated the study of invertebrate immunity at the end of the 
18
th
 century. He paved the way to the understanding of innate immunity both in vertebrates 
and invertebrates (Levashina, 1995). By the year 1930 it was known that the insect defense 
includes a cellular and a humoral facet (Hoffmann, 1995). Insects depend on multiple innate 
defense reactions to fight infection, which include the use of physical barriers in combination 
with systemic and local immune responses (Duvic, et al. 2012). In insects, the first line of 
defense against pathogens is the tough cuticle covering the entire animal. Upon breach of this 
barrier, local immune response occurs at the pathogen penetration site, and the response 
becomes systemic by using the open circulatory system of insects. Systemic and local defense 
reactions both depend on cellular and humoral mechanisms (Girard, et al. 2007). It is 
currently known that the innate response of insects depends on three tightly interconnected 
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reactions. The first reaction entails the induction of proteolytic cascades by wounding. It 
involves the coagulation cascade that results in localized blood clotting and the 
prophenoloxidase cascade (melanisation) that leads to the formation of melanised nodules 
and toxic reactive compounds (Hoffmann, 1995). Cellular defense reactions are the second 
reactions that consist of encapsulation of invading microorganisms, nodulation and/or 
predominantly phagocytosis. Phagocytosis consists of the engulfment of small objects such as 
apoptotic cells, bacteria or yeast by plasmatocytes (Feldhaar & Gross, 2008). The third 
reaction occurs in the fat body where batteries of AMPs are synthesized (Hoffmann, et al. 
1996).   
 
1.2 Antimicrobial peptides 
 
The identification of small proteins that are important in immune defense can be traced back 
to 1921 when lysozyme was discovered by Alex Fleming (Wang, 2013; Fleming, 1881-
1955). In a landmark study, from the blood of immune-challenged pupae of Hyalophora 
cecropia, an AMP was isolated in the year 1981. The peptide named cecropin, a 4 kDa 
peptide mainly active against Gram-negative bacteria, has since been isolated from various 
sources (Levashina, et al. 1995). To date, a number of AMPs have been isolated from sources 
such as plants, invertebrates, vertebrates, eggs and humans (Memarpoor-Yazdi, et al. 2012). 
In total, there are 5 from protozoa, 10 from fungi, 181 from bacteria, 293 from plants and 
1656 AMPs from animals (including insects). Over 2000 natural AMPs are registered into the 
antimicrobial peptide database (APD) (Wang, 2013).  
 
Figure 1.1: Sources of antimicrobial peptides (in total: 2183) in the AMP database. The three major 
sources bacteria (8%), plants (13%) and animals (including insects) (76%) (Wang, 2013). 
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In the main insect orders such as Diptera, Lepidoptera, Coleoptera, Hemiptera and 
Hymenoptera, AMPs have been characterized (Yoon, et al. 2003; Duvic, et al. 2012). The 
most powerful and highly characterized components of the systemic humoral response are 
AMPs (Girard, et al. 2007). They are a conserved component of immunity in plants and 
animals. Mostly small-sized with a molecular mass below 25-30 kDa, AMPs typically have 
12-50 amino acid residues. They are mostly cationic as a result of a positive net charge at 
physiological pH (Gough, et al. 1996; Bowdish, et al. 2005) and they have a pI range 
between 8.9-10.7 (Li, et al. 2012). AMPs usually have a small number of acidic residues such 
as aspartate and glutamate which presumably contributes to the increase of amphipathicity 
when present on the polar face (Teixeira, et al. 2012).  Moreover, they usually present up to 
50% hydrophobic amino acids, contributing to the common amphipathic conformation that 
they tend to assume at the lipid-membrane interface when interacting with the target cell 
(Papo & Shai, 2003).  According to Li, et al. (2012), they are also known to be heat-stable 
(100
0
C, 15 minutes).    
  
AMPs can contain various modifications and vary tremendously in sequence and structure 
even within a single species. These peptides have a relatively rapid sequence divergence of 
the regions encoding mature peptides (Bowdish, et al. 2005). While they have diverse 
structures, most AMPs can be assigned to larger families such as cecropins, attacins, 
defensins and diptericins (Casanova-Torres & Goodrich-Blair, 2013). 
 
AMPs are multifunctional molecules that are involved in several biologic processes and 
pathologic conditions such as cell proliferation, immune modulation, cytokine and histamine 
release, wound healing, allergic reactions, anticancer activity, angiogenesis, chemotactic 
activity and topical activity (Scott & Hancock, 2000; Bowdish, et al. 2005). The 
antimicrobial peptides database in 2011 indicated that there are antiviral (5.8%), antitumor 
(6.14%), antifungal (31.91%) and antibacterial (78.56%) peptides (Seebah, et al. 2007). 
AMPs have been called natural antibiotics because of their large spectrum of activity. Some 
AMPs can be used as anti-parasites to control disease. They can be applied in treatment of 
infected hosts or in prevention of disease transmission by interfering with parasites in their 
insect vectors. For future applications, AMPs are being recognized as potential antimicrobial 
alternatives to common antibiotics and chemical food preservatives (Li, et al. 2012). 
Structures of more than 231 AMPs have been determined by use of studies in nuclear 
magnetic resonance and X-ray diffraction (Seebah, et al. 2007). 
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1.3 Classification of AMPs 
 
The most common classification of AMPs is divided into three broad classes based on 
sequence and structural features (Bulet, et al. 1999): linear peptides with amphipathic α-
helices, cysteine-stabilized α-helical/β-sheet motif containing peptides, and linear peptides 
with an over-presentation in glycine and/or proline residues (Duvic, et al. 2012). 
 
Figure 1.2: Prototypic structures of classical antimicrobial peptide groups. Left to right: Linear α-
helical, cysteine-stabilized α-β, and specific amino acid enriched. (Yount, et al. 2006). 
  
The largest group of AMPs known to date is the linear cationic -helical peptides where 
more than 300 different members have been described (Adade, et al. 2013). The most 
important representatives of this group are cecropins, magainins, cathelicidins and melittin 
(Wachinger, et al. 1998). These AMPs have been discovered from many different sources 
such as extracellular fluids of insects, invertebrates, teleost fish, nematodes, frogs and 
mammalian neutrophils. They typically have 12-37 residues and may have a central hinge 
region. Many of these peptides exist in aqueous solution as unstructured conformers. 
However, they usually become helical within membrane mimetic environments (Yount, et al. 
2006). They lack cysteine residues, and form two linear α-helices that are connected by a 
hinge. Their integration into the acidic membranes of pathogens leads to destruction of the 
pathogen membrane (Li, et al. 2012).  
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The -sheet AMPs have a well-defined number of -strands with relatively few helical 
domains or none (Yeaman & Yount, 2003). The -strands are typically organized in the 
common amphipathic pattern (Ganz, 2003). Most of these peptides are constrained either by 
cyclization of the peptide backbone or by disulfide bonds (Kang, et al. 2012). The -sheet 
peptides containing cysteine represent a very diverse group of molecules which are mainly 
represented by defensins. The stability of these peptides is due to a series of up to six 
disulfide bonds and they are frequently formed by several antiparallel -strands. A common 
motif that is responsible for the integration of all the classes of cysteine-stabilized 
antimicrobial peptides has been discovered through multidimensional proteomic analysis. 
This motif, known as the γ-core, consists of two antiparallel β-sheets which have basic 
residues polarized along the axis (Ganz, 2003). The γ-core motif is found in all major classes 
of cysteine-stabilized host-defense peptides (Yount, et al. 2006). -sheet AMPs have potent 
activity against some fungi, Gram-negative bacteria, protozoa and yeasts, but they are 
predominantly effective against Gram-positive bacteria (Li, et al. 2012). 
 
There are numerous examples of AMPs that do not present a specific type of motif, instead 
they are defined by the presence of a predominant amino acid that imposes certain constrains 
on their structure. Studies have shown that the structures of these peptides generally differ 
from the prototypic β-sheet and α-helical structures. This group of AMPs includes those that 
contain relatively high amounts of proline, glycine and arginine, tryptophan (indolicidin), and 
histidine residues (Yount, et al. 2006). The glycine-rich (14-22% glycine residues) AMPs 
usually act against Gram-negative bacteria, fungi and cancer cells by the destruction of cell 
membranes. Proline-rich AMPs are known to be isolated from mammals and insects. They 
are mainly effective against Gram-negative bacteria and some human pathogens. This group 
differs from other types of AMPs in that their mode of action consists of penetration into 
susceptible cells, where they then act against intracellular targets (Li, et al. 2012). 
 
Some of these peptides are not so recurrent, and hence are less studied. Recently, 
antimicrobial activity has been found in polypeptides and proteins considerably larger than 
classical short AMPs. Some of the smaller peptides were shown to result from proteolytic 
cleavage from these larger precursors (Nibbering, et al. 2001).  
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The peptides assume the above-mentioned conformations after coming into contact with the 
target membranes. Interactions with the phospholipid bilayer in the pathogens cell 
membranes are facilitated by the AMPs characteristic physicochemical properties (Shai, 
1999).  AMPs can be produced by insects constitutively at local sites and they can also be 
released systemically after infection by pathogen to generate pathogen-killing activities. 
According to Lamberty, et al. (2001), insects have two modes of fighting infections by 
AMPs. First, is the inducible production of AMPs which occurs after septic injury by 
transcription of genes coding for AMPs in the fat body. AMPs are then rapidly released into 
the hemolymph. The second mode is constitutive, in which AMPs are produced and stored in 
the haemocytes, and then released into the hemolymph following immune challenge. 
 
1.4 Secretion of AMPs 
 
The secretion of AMPs varies according to differences in physiological settings. In some 
physiological settings, they are secreted into internal body fluids or onto wet mucosal 
surfaces (Kang, et al. 2012). AMPs contribute a component of the non-oxidative killing 
activity of phagocytic defensive cells in other settings. The major site of synthesis of 
immune-induced AMPs is the fat body (Zasloff, 1992), which is also considered to be the 
functional equivalent of the mammalian liver. Minor sites of AMP synthesis include 
hemocytes and other tissues such as Malphigian tubules, pericardial cells and the midgut. 
AMPs are also induced in response to infection in the cuticle or wounding in epidermal cells 
(Gillespie, et al. 1997). AMPs such as the insect defensin can also be produced by salivary 
gland cells and gut cells (Hoffmann, 1995). In some species, genital tract cells, in both males 
and females, also produce AMPs. The insect fat body is induced by septic injury to 
immediately synthesize a large spectrum of antifungal and antibacterial peptides. These 
peptides are released into the hemolymph to destroy invading microorganisms (Zasloff, 
1992).  
 
In a review article by Concciancich, et al. (1994), it was shown that the injection of insects 
with attenuated bacterial cultures caused a resistance to subsequent injections of virulent 
bacteria. Induction of resistance occurred simultaneously with the appearance of a potent 
antibacterial activity in the cell-free hemolymph. According to a review by Hoffmann, 
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(1995), inducible antimicrobial peptides are produced in the fat body within 0.5-1 hour after 
injury or bacterial challenge (Levashina, et al. 1995). 
 
1.5 Signal transduction pathways 
 
The primary regulation of the expression of AMPs at transcriptional level occurs through two 
distinct signalling cascades called the Imd and Toll pathways which are phylogenetically 
conserved (Girard, et al. 2007). Innate immune recognition consists of specific interactions 
between pattern-recognition receptors (PRRs) and pathogen associated molecular patterns 
(PAMPs), and intracellular signal transduction cascades that lead to the synthesis of 
antibacterial/antifungal peptides. Innate immune recognition starts with the detection of 
conserved structural products of microorganisms. The recognition process enables few germ-
line encoded PRRs to recognize any microbial infection. Effector mechanisms of innate 
immunity are triggered by the presence and recognition activity of PRRs in insect 
hemolymph. Molecular and genetic studies led to a detailed characterization of the signal 
transduction pathways upon discovery of PRRs known as Toll-like receptors (TLR) and 
Immune deficiency (Imd) in Drosophila melanogaster (Brivio, et al. 2006; Hancock, et al. 
2006).  
 
Gram-positive bacterial peptidoglycan or fungal β-glucan initiates the Drosophila Toll 
pathway through interaction with peptidoglycan-recognition proteins (PGRPs) and Gram 
negative binding proteins (GNBPs) which finally activate a serine protease cascade. 
Activated enzymes eventually cleave the cysteine-knot cytokine-like protein Spätzle. The 
dimeric form of the mature Spätzle binds to and activates the ectodomain of two Toll 
receptors. Three proteins containing serine-threonine kinase domains interact with the 
intracytoplasmic domain of Toll (Bulet & Stocklin, 2005). This triggers a signal transduction 
pathway that results in phosphorylation of an Iĸβ-like inhibitor Cactus which causes it to 
dissociate from the NF-ĸβ-like dorsal-related immunity factor (DIF) in adults or Dorsal 
and/or DIF in larvae. DIF and/or Dorsal activate numerous antimicrobial genes after 
translocation to the nucleus (Bulet & Stocklin, 2005; Hancock, et al. 2006).  The Toll-Dorsal 
pathway in Drosophila is a conserved signalling pathway that is used in both vertebrates and 
invertebrates in different biological contexts. The pathway is used in other processes such as 
morphogenetic movements and muscle development (Belvin & Anderson, 1996). 
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The IMD pathway in Drosophila is predominantly implicated in the regulation of genes 
encoding anti-Gram-negative AMPs (Bulet & Stocklin, 2005). Moreover, the pathway 
responds mainly to peptidoglycan through a distinct PRR, PGRP-LC. This leads to activation 
of another kinase-based signal transduction pathway which causes phosphorylation and 
subsequent translocation of another NF-ĸβ-like transcription factor known as Relish into the 
nucleus. Relish is cleaved into two parts and, ultimately, the transcription factor regulates 
transcription of immune-related genes (Hoffmann & Reichhart, 2002). Various studies 
provide evidence which suggests that Drosophila has the ability to differentiate between 
pathogens and to mount the most appropriate immune response to fight against infection 
(Bulet & Stocklin, 2005).   
 
 
Figure 1.3: Schematic overview of the signalling pathways that trigger an immune response in D. 
melanogaster. (Feldhaar & Gross, 2008). 
  
Recent studies in coleopteran immunity are beginning to reveal the nature of their    
signalling network. Specifically studies on larger beetles such as Tenebrio molitor and 
Holotrichia diomphalia show that beetles respond to β-1,3-glucans and to lysine-containing 
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peptidoglycan and polymeric diaminopimelic acid containing peptidoglycans, by using the 
Toll signalling pathway. Both types of PAMPs form complexes with Gram-negative binding 
protein 3(GNBP3) in fungi and peptidoglycan recognition protein in Gram-negative bacteria. 
The serine protease cascade is activated by both complexes via a modular serine protease 
which is an apical protease, followed by two types of CLIP domain serine proteases at 
penultimate and terminal positions before pro-Spätzle. This leads to the generation of active 
Spätzle, the ligand of the transmembrane receptor Toll. Subsequent intracellular signalling 
results in the transcriptional activation of genes that code for AMPs (Park, et al. 2010; 
Ntwasa, et al. 2012).    
Findings by Hull, et al. (2013) suggest that E. intermedius responds to fungal challenge via 
the Toll signalling pathway.  
  
Loss of effector responses that leads to impairment of the host’s ability to eliminate foreign 
invaders can result from any disturbance with the PAMP-PRR recognition process. From data 
reported by Brivio, et al. (2006), it was concluded that the absence or lack of PRRs from 
insect hemolymph leads to avoidance of the triggering of an antimicrobial response among 
other immune processes.     
 
1.6 AMPs mechanism of action 
 
It is generally accepted that membrane permeabilization is the main mechanism by which 
antimicrobial peptides act against pathogens. Upon membrane permeabilization, the 
electrochemical potential dissipates along with lipid asymmetry. Subsequent loss of 
metabolites and cellular components usually results in cell shrinkage and ultimately cell death 
(Yeaman & Yount, 2003). Previous studies have shown that some AMPs translocate into the 
cytoplasm of the pathogen and interfere with the function of nucleic acids. Other AMPs enter 
the cytoplasm of the pathogen and kill it by targeting intracellular molecules (Hale & 
Hancock, 2007). In order to confirm the actual mechanism of action of antimicrobial peptides 
with intracellular targets, more studies are required (Ntwasa, et al. 2012).  
   
The cell membrane is considered as a bilayer of phospholipids that regulate the flux of 
metabolites between the external environment and the intracellular content. The crucial basis 
for lipid assembly into structural and functional membranes is the physicochemical nature of 
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membrane lipids. In pathogens, the membrane is the main target of most antimicrobial 
peptides. One of the most prominent factors that modulate the peptide’s activity upon 
interaction of the peptide with the membrane is known as the membrane electrical potential. 
The membrane electrical potential, which is dictated by electrostatic interactions between the 
lipid head groups and the cationic peptides, also modulates the extent of the peptide’s 
partition to the membrane. The nature of lipids dictates the curvature strain of the membrane. 
The unsaturated type II lipid phosphatidylethanolamine (PE) naturally promotes a negative 
curvature strain in monolayers due to its inverted cone geometry. In contrast, the 
phosphatidylcholine (PC) and phosphatidylglycerol (PG) lipids do not have that propensity 
due to their cylindrical molecular shape. Moreover, the hydrophobic interactions between the 
hydrocarbon acyl chain and the amphipathic peptide can induce lipid packing frustration such 
as membrane thinning. These interactions also have a great impact on membrane structure by 
causing membrane disruption and permeabilization (Teixeira, et al. 2012). 
  
The difference of charge between lipids on the membrane of pathogens and cationic peptides 
are considered crucial in pathogen killing (Shai, 1999). Most antimicrobial peptides have a 
net positive charge ranging from +2 to +9. Cationicity of AMPs may be essential for their 
initial electrostatic attraction to bacteria and fungi through their electronegative cell 
envelopes and phospholipid membranes. At the outermost surface of pathogens, cationic 
peptides encounter the glycocalyx and/or cell wall of the bacteria and fungi (Yount, et al. 
2006). The surfaces of bacterial cells have negatively charged components such as 
teichuronic and teichoic acids of Gram-positive bacteria, and the anionic lipids and 
lipopolysaccharide (LPS) of Gram-negative bacteria. Phosphatidylglycerol (PG), 
phosphatidylserine (PS) and cardiolipin (CL) are hydroxylated phospholipids that have a net 
negative charge at physiological pH and are predominant on pathogen membranes (Lohner, et 
al. 2001; Zhu, et al. 2014). In contrast, phospholipids that comprise the outer surface of 
normal mammalian cell membranes are predominantly composed of zwitterionic cholesterol 
and phospholipids (Papo & Shai, 2003). This trait partially explains the specificity of cationic 
AMPs towards pathogens. Therefore, the key molecular determinant of the selective activity 
of AMPs towards pathogens seems to be the higher proportion of anionic lipids at the 
pathogen membrane surface that results in a significantly higher negative electrical potential 
(-130 mV to -150 mV) (Hancock, 1997).  
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It is noteworthy to list advantages of using E. coli as a pathogen that stimulates immune 
response in this particular study.  Firstly, it is a Gram-negative bacterium. Most antimicrobial 
peptides have a net positive charge that ranges from +2 to +9, and as already mentioned, 
cationicity of AMPs may be important for their initial electrostatic attraction to bacteria and 
fungi (Yount, et al. 2006). It has been stated by Li, et al. (2012) that there are more AMPs 
with functions of anti-Gram-negative bacteria than those with the functions of anti-Gram-
positive bacteria. For instance, AMPs such as attacins, cecropins, diptericins and drosocins 
are predominantly active against Gram-negative bacteria.  
 
It has become clear that anionic AMPs are also an essential part of the innate immune system. 
Over the last ten years, more than 100 anionic peptides were identified in vertebrates, 
invertebrates and plants (Harris, et al. 2009). These peptides were first reported in the 80
s
 and 
they present a similar broad spectrum of action as their cationic counterparts. They are active 
against fungi, viruses, bacteria and pests such as insects (Phoenix, et al. 2013). However, 
these peptides were generally found to have weak antibacterial activity against various Gram-
negative and Gram-positive bacteria, which was enhanced by the addition of Zn
+
 or post-
translational modification (Harris, et al. 2009). Some antimicrobial properties have been 
described for small anionic peptides rich in aspartic and glutamic acids. They have a net 
charge ranging from -1 to -7, and in length they range from 5 to 70 residues. The mechanisms 
of action for anionic peptides are not yet fully understood (Brogden, 2005; Harris, et al. 
2009).   
 
Amphipathicity is crucial for the action of all AMPs since most of them fold into amphipathic 
structures upon interaction with pathogen membranes. The definition of amphipathicity is 
relative distribution and proportion of hydrophilic and hydrophobic residues within a peptide. 
One of the simplest amphipathic structures is the α-helix. Most α-helices have a periodicity of 
3-4 residues per turn, which is optimal for interaction with biomembranes (Yount, et al. 
2006). Amphipathicity is greatly correlated with peptide toxicity and antimicrobial efficacy. 
Molecules with high amphipathicity tend to disrupt the zwitterionic membranes of 
mammalian cells (Teixeira, et al. 2012).  
  
Peptide hydrophobicity is defined as the proportion of hydrophobic residues within a peptide. 
It typically constitutes ~50% for most AMPs (Yeaman & Yount, 2003). Moderate 
hydrophobicity is needed for AMP activity as it controls the degree of partitioning of peptide 
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into lipid bilayers. However, excessive levels of hydrophobicity result in loss of antimicrobial 
specificity and cause mammalian cell toxicity. Many AMPs have moderate hydrophobicity 
(Wieprecht, et al. 1997; Yount, et al. 2006).    
 
1.7 Models of AMPs mechanisms of action 
  
Several models have been proposed to describe mechanisms used by AMPs to disrupt 
pathogen membranes. A given AMP may act through different mechanisms in different 
membrane environments, due to the variability in microbial membrane ultrastructure 
(Yeaman & Yount, 2003). 
 
 
Figure 1.4: Models of mechanisms of action for AMPs. (Li, et al. 2012). 
  
First, there is the “barrel-stave” model. The term barrel-stave defines the membrane channel 
topology that is formed in this mechanism. A variable number of channel-forming peptides 
are located around an aqueous pore in a barrel-like ring. The individual transmembrane 
spokes within the barrel form the “stave”. These spokes may consist of peptide complexes or 
individual peptides. In the barrel-stave mechanism, the hydrophobic surfaces of β-sheet or α-
helical peptides are outwardly faced toward the membrane acyl chains, whereas the pore 
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lining is formed by the hydrophilic surfaces (Ehrenstein & Lecar, 1977; Breukink & Kruijiff, 
1999). The formation of the transmembrane pore involves the following steps: the membrane 
is bound by the peptide monomers in a helical fashion, and subsequently, the helices insert 
into the hydrophobic core of the membrane. After binding, the peptide may undergo a 
conformational phase transition which results in induction of localized membrane thinning. 
As the bound peptide reaches threshold concentration, self-aggregation of peptide monomers 
occurs which leads them to insert deeper into the hydrophobic membrane core. Pore 
formation re-orientates the helix from the parallel state to the perpendicular membrane 
spanning state. Additional monomers are progressively recruited resulting in increased pore 
size and leakage of cell contents and ultimate cell death (Reddy, et al. 2004).   
  
Second, in the “carpet” model the peptides solubilize the membrane as they interact with the 
lipid head groups on the pathogen cell surface. The carpet model differs from the barrel-stave 
model in that the peptides do not insert into the membrane hydrophobic core and they do not 
assemble with their hydrophilic surfaces facing each other. Reddy, et al. (2004) described 
steps of the carpet mechanism as follows: the peptides firstly bind to the surface of the target 
membrane covering it in a carpet like manner. Subsequently, alignment of peptide monomers 
on the membrane surface occurs as their hydrophilic surfaces face the phospholipid head 
groups (or water molecules). The hydrophilic residues are then orientated towards the 
hydrophobic core of the membrane. Reductions in membrane barrier properties and/or 
phospholipid displacement changes in membrane fluidity subsequently lead to membrane 
disintegration. Membrane disruption occurs in a dispersion-like manner that excludes channel 
formation (Shai & Oren, 2001). Furthermore, no specific quaternary structure is required in 
the steps of the carpet mechanism. Thus, when a threshold peptide concentration is reached, 
the membrane is exposed to unfavorable energetics leading to loss of membrane integrity. 
This model was also proposed for viral killing (Papo & Shai, 2003). 
 
Finally, the “toroidal” model is one of the most well characterized mechanisms of action. In 
this model, antimicrobial peptides partition into the membrane and continuously induce a 
bending in membrane leaflets through the pore. Thus, the water core is lined by both lipid 
head groups and inserted peptides. This model primarily differs from the barrel-stave model 
in that lipids are intercalated with peptides in the transmembrane channel. Hence, this 
structure is also known as a supramolecular complex that represents a membrane-spanning 
pore lined with phospholipid head groups as well as polar peptide surfaces. In the toroidal 
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mechanism, peptides in the extracellular environment take on the α-helical structure upon 
interaction with the hydrophobic and charged bacterial membrane. Initially, helices are 
oriented parallel to the membrane surface. The polar head groups are displaced by 
hydrophobic residues of bound peptides, inducing a positive curvature strain in the membrane 
by creating a breach in the hydrophobic region (Hara, et al. 2001). The membrane surface 
integrity is further destabilized by introduction of strain and thinning. Peptides orient 
perpendicular to the membrane at a threshold peptide-to-lipid ratio. Helices begin to 
aggregate, such that their polar residues are no longer exposed to the membrane hydrocarbon 
chains. Peptide aggregation, either prior or after binding to the membrane, seems to be 
required for pore formation, although a stable secondary structure is not required. An 
unfavorable elastic tension is created that may lead to the formation of transient defects and 
eventually pore disintegration (Teixeira, et al. 2012). Therefore, the transient and multimeric 
composite forms the dynamic peptide-lipid toroidal pore or supramolecular complex. As the 
pore disintegrates, some peptides are translocated to the cytoplasmic leaflet of the membrane, 
which suggests that disintegration of the toroid pore allows entrance of peptides into 
microbial cytoplasm in order to access potential intracellular targets (Yeaman & Yount, 
2003).  
 
The aggregate channel model was proposed based on the finding that membrane 
depolarization by itself is not necessarily a required step in pathogen killing by some 
peptides. In this model, peptides bind to the phospholipid head groups and then insert into the 
membrane (Costa, et al. 2011). Subsequently, they cluster into unstructured aggregates that 
cover the membrane and then water molecules associate to these aggregates that consequently 
provide channels for the leakage of ions and possibly larger molecules through the membrane 
(Li, et al. 2012). Only short-lived transmembrane clusters are formed, which allow the 
peptides to transiently cross the membrane without causing high membrane depolarization 
and membrane structure destruction (Costa, et al. 2011). This distinguishes the aggregate 
channel model from the other models.  Upon entrance of peptides into the pathogen, they 
exert their lethal activities to their intracellular targets by acting on polyanions, such as DNA 
or RNA (Brogden, 2005). 
 
Both the toroidal and carpet models suggest that the killing activity of antimicrobial peptides 
occurs due to collapse in membrane integrity followed by dissipation of the membrane 
potential. However, studies have provided evidence that transmembrane pores, ion channels 
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and extensive membrane rupture followed by leakage of metabolites and intracellular content 
in general do not proceed through three different mechanisms of action, but are instead a 
continuous gradation between them (Teixeira, et al. 2012). Moreover, peptides may kill the 
same organism using more than one mode of action. It depends on varying factors such as 
tissue localization, growth phase and the presence or absence of other immune mechanisms 
(Yeaman & Yount, 2003). 
 
1.8 Mechanism of cell death 
 
Increasing evidence supports the suggestion that membrane permeabilization alone is not 
enough to cause cell death. Microorganisms may survive for longer periods of time following 
membrane permeabilization in some cases, implicating that non-membranolytic mechanisms 
may be responsible for cell death. In some instances, cell killing has been reported to proceed 
with little membrane disruption, but rather due to disruption of intracellular processes 
(Hancock & Chapple, 1999). Some of the factors that are involved in these intracellular 
processes were extensively described in a review article by Yeaman & Yount, (2003), 
namely, inhibition of extracellular biopolymer synthesis, inhibition of intracellular functions 
and membrane dysfunction. 
 
The cytoplasmic membrane mediates many important functions in microbial pathogens. 
Antimicrobial peptides may interfere with some of the crucial cytoplasmic membrane 
functions, which may lead to cell death indirectly or directly. Inhibition of chitin, 
peptidoglycan or other macromolecular synthesis may also play an essential role in the 
mechanism of AMP action. For example, biosynthesis of peptidoglycan is integrally 
associated with membrane function and integrity (Blondelle, et al. 1999). Studies have also 
shown that disturbance of key intracellular processes may be required for cell death (Lehrer, 
et al. 1989; Park, et al. 1998).   
1.9 Therapeutic potential of AMPs 
 
In the early 1970s, it was assumed that any bacterial infection could be treated, due to 
availability of numerous and widely ranged antimicrobial agents. These agents, called 
antibiotics, were products isolated from few bacterial and fungal species. The assumption was 
soon proved to be incorrect when pathogens appeared to be resistant to conventional 
17 
 
antibiotics that are used routinely to treat bacterial infections (Reddy, et al. 2004).  The 
widespread antibiotic consumption both outside and inside of medicine plays a major role in 
the emergence of antibiotic-resistant bacterial strains (Memarpoor-Yazdi, et al. 2012). 
Incorrect use of antibiotics results in increased levels of bacterial resistance. Excessive use of 
antibiotics in non-established infections or in infections with viral etiology has served as a 
form of selective pressure for the appearance of increasingly resistant microorganisms (Fiol, 
et al. 2013). Only few antibiotics that provide successful response to infection are available. 
In the 80
s
, 16 new compounds appeared, and that number decreased to only 7 between 1998 
and 2002 (Spellberg, et al. 2004). It is, therefore, clear that antibiotics are no longer a reliable 
weapon against infections.  
 
The development of new classes of antimicrobial therapeutic drugs and vaccines is very 
crucial due to factors such as: the emergence of multiple-drug resistance, the low rate of 
discovery of new antibiotics and the alarming death rate caused by infection. The 
development of alternative means to fight infection is required (Ntwasa, et al. 2012). AMPs 
have long attracted commercial and scientific interest due to their capability to kill bacteria 
without being harmful to human cells (Sovadinova, et al. 2011). According to Cytrynska, et 
al. (2006), AMPs are now considered to be important targets for development of therapeutics 
against various pathogens. In vertebrates, AMPs mediate a number of cellular processes such 
as wound healing, immunomodulation and tumorigenesis (Scott & Hancock, 2000). They are 
key effector molecules in host defense through direct and indirect antimicrobial activity. 
These roles increase the potential to develop therapeutic products and vaccines from AMPs 
(Ntwasa, et al. 2012). In addition, AMPs are fast acting, highly selective and effective against 
various pathogens. AMPs have shown their ability to rapidly kill a broad spectrum of 
microorganisms including fungi, bacteria and viruses (Reddy, et al. 2004). They also combat 
other pathogens including protozoa. Therefore, AMPs are less likely to cause the emergence 
of resistance currently experienced with traditional antibiotics. Another essential benefit of 
AMPs as therapeutics is that their mechanism of action is more physical rather than targeting 
metabolic pathways, thus reducing the emergence of resistance (Andrés & Dimarcq, 2005; 
Cytrynska, et al. 2006; Ntwasa, et al. 2012).  
 
A crucial prerequisite for development of AMPs into therapeutics is selective toxicity. AMPs 
act only on foreign microorganisms while retaining the structural and functional integrity of 
host cells. Since they are able to kill a broad spectrum of microorganisms, AMPs have taken 
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advantage of biochemical divergence and evolution inherent to cell membrane composition to 
be harmless to host cells while acting preferentially on pathogens (Teixeira, et al. 2012). This 
difference is considered to possibly account for the varying levels of effectiveness that AMPs 
have against different types of cells. Prokaryotic and eukaryotic cell membranes differ 
considerably in lipid composition. Since lipid composition is thought to be the basis of 
specificity of AMPs towards the target cell, the difference of lipid composition of cell 
membranes is particularly important for the action of AMPs. The anionic lipids of pathogens 
are present on the outer surface of the membrane, whereas they are present along the 
cytoplasmic side of the membrane of mammalian cells (Reddy, et al. 2004). The difference of 
lipid composition and distribution confers selectivity toward prokaryotes and reduces toxicity 
toward host tissues (Yeaman & Yount, 2003). Another contributing factor is the lack of 
rigidifying lipids such as cholesterol on pathogen membrane as compared to host cell 
membranes (Teixeira, et al. 2012).   
 
The most obvious use of antimicrobial peptides as potential therapeutics is to amplify the 
antimicrobial efficacies of conventional antibiotics. An example is the access-based 
resistance mechanisms such as enhanced efflux or reduced uptake that may be overcome by 
conventional antibiotics through facilitation by AMPs. As an alternative, peptides interacting 
with targets or intracellular processes could be engineered to assist the mechanisms of 
classical antibiotics noncompetitively. Molecular determinants that are emerging as potential 
targets for AMP strategies include energetics, metabolic processes, essential pathways, 
microbial receptors, intracellular targets as well as virulence factors. The concept that AMPs 
may be used to treat or prevent infections is not novel. For many years AMPs have been 
utilized to prevent or treat infections. Gramicidins, polymyxins and bacitracin can be found in 
many topical applications and have been used for decades. Advances in understanding 
mechanistic and structural aspects of AMPs are increasing the development of improved anti-
infective peptides (Yeaman, et al. 2002; Zasloff, 2002).  
 
It is essential to consider that the development of commercially viable peptides is faced with 
many challenges. In a review article, Ntwasa, et al. (2012) listed some of the major 
challenges, including pharmacokinetics. Pharmacokinetics describes how the body deals with 
drugs. During oral administration of peptides, the gastrointestinal tract may hinder their 
reabsorption into the systemic circulation. Moreover, when peptides are injected directly into 
the blood, they may elicit an antigenic response. For this reason, AMPs cannot be applied as 
19 
 
injectable therapeutics. Topical medication appears to be the most feasible formulation at 
present (Jiang, et al. 2007; Yeung, et al. 2011). Despite current challenges, very few peptides 
have obtained FDA approval for clinical use. Some AMPs have proceeded to clinical 
application and some are undergoing clinical trials. They have also been shown to work in 
combination with conventional antibiotics to protect against systemic and topical infections 
(Reddy, et al. 2004). Therefore, there is optimism that the challenges may soon be overcome 
(Ntwasa, et al. 2012). Databases such as the APD serve as useful tools for the discovery and 
design of new peptides (Lata, et al. 2010).  
 
1.10 Euoniticellus intermedius 
 
Euoniticellus intermedius is of the Coleopteran order which is the largest and most diverse 
insect order on earth. E. intermedius (Coleoptera: Scarabaeidae) is well known as the dung 
beetle and largely found in the Afrotropical region. The dung beetles make tunnels beneath 
dung pats where they feed and reproduce. The microbe-rich liquid portion of manure feed 
provides nutrients for adult dung beetle but they do not actually consume the dung. The dung 
beetle larvae are laid in brood balls where they consume most of the dung (Khanyile, et al. 
2008). The species is important because it has a wide ecological tolerance and nesting 
strategies which vary according to the season and soil type. Therefore, it can survive under 
extreme climatic and edaphic conditions (Kruger, et al. 1999). 
 
Coleopterans thrive on this planet although they have no adaptive immunity. There is 
evidence that Coleoptera have retained many of their ancestral genes, which could provide 
more knowledge about the properties and evolution of innate immunity. More work on innate 
immunity has been performed using Drosophila, representing dipterans, while fewer studies 
have focused on coleopterans and their innate immunity (Hoffmann, 2004). The evolutionary 
history and lifestyle of dung beetles indicate an interesting immune system that could be 
more comparable to vertebrate innate immunity than D. melanogaster. For example, some 
signalling pathways components that are conserved in coleopterans and vertebrates are not 
conserved in D. melanogaster (Hull, et al. 2013).  
 
AMPs from the Coleoptera have been studied in very few insect species such as Tenebrio 
molitor, H. diomphalia, Zophobas atratus and others (Yoon, et al. 2003). According to Yoon, 
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et al. (2003), the finding of antimicrobial peptides in other coleopteran species will be helpful 
in understanding insect immune responses and their molecular mechanisms. Molecular 
studies of E. intermedius are in progress with a view to study its immune system. This beetle 
has a wide ecological tolerance and survives under extreme environments, thus, interest to 
study the immune system of these beetles is primarily due to their microbe-rich habitat. Their 
immune system could provide useful strategies for treatment of infectious diseases affecting 
humans (Khanyile, et al. 2008). 
 
1.11 Aims of the study 
 
The current study focused on analysis of immune response of South African Euoniticellus 
intermedius embryonic (SAEIE08) cell line upon exposure to pathogens, specifically 
Escherichia coli and Micrococcus luteus. E. coli was used to represent Gram-negative 
bacteria and M. luteus was used as a representative of Gram-positive bacteria. The study 
aimed to show that SAEIE08 has constitutive and/or inducible antimicrobial activity. Another 
major aim of the study was the isolation and identification of cationic antimicrobial peptides 
from SAEIE08. Antimicrobial activity upon exposure to pathogen was monitored by 
performing solid and liquid bacterial inhibition assays. The study was followed by analysis of 
changes in protein expression patterns of SAEIE08 following exposure to pathogens. The 
changes were monitored using one dimensional SDS-PAGE and 2-D PAGE. The 5′/3′ RACE 
kit was employed in conjunction with general molecular biology techniques for the isolation 
and identification of genes that encode antimicrobial peptides with subsequent utilization of 
the NCBI database and Bioinformatics to search for identical sequences.   
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Chapter 2: Materials and Methods 
2.1 Materials 
 
See Appendix 1 for materials on page 53. 
 
2.2 Methods 
 
The first sections of the methodology primarily focused on techniques used to show evidence 
which suggests that there is in fact antimicrobial activity in the South African E. intermedius 
embryonic cell line (SAEIE08). Before the study proceeded to isolating and identifying 
antimicrobial peptides, it was essential to firstly prove the presence of antimicrobial activity 
in SAEIE08. Therefore, growth inhibition assays were used to study immune response in 
SAEIE08 upon exposure to E. coli. Such assays were accompanied by the agarose overlay 
method. In order to analyse protein expression patterns, SDS-PAGE and 2-D PAGE were 
employed. The 5′/3′ RACE kit was used for the isolation of RNA, which was converted to 
cDNA, amplified and subsequently sequenced for identification and characterization. The 
method included general molecular biology techniques, sequencing, bioinformatics and the 
NCBI database searches.  
 
2.2.1 Organism maintenance, challenging and preparation  
 
2.2.1.1 Preparation of heat-killed bacteria 
  
E. coli, strain 1106, was maintained on LB agar plates without antibiotics. A single colony of 
E. coli was inoculated into 2 ml LB broth for preparation of bacterial culture. Bacterial cells 
grown at 37
0
C on a shaking incubator were collected in the exponential phase of growth and 
suspended in sterile saline. The optical density at OD650 of cell suspension was adjusted to 
0.3. using a spectrophotometer. Cell suspension was washed twice and re-suspended in 1 ml 
sterile saline. Aliquots of the re-suspended solution were serially diluted and subsequently 
plated with 100 µl spread on each plate, and then colonies were counted the following day in 
order to determine the concentration of stock E. coli, which was ~4 x 10
6 
CFU/ml. Plates 
were incubated overnight at 37
0
C. Half of the remaining stock was kept frozen at -20
0
C and 
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the other half was heat-killed at 80
0
C for an hour. Sterility of the heat-killed bacteria was 
tested by plating 100 µl overnight at 37
0
C.  
 
2.2.1.2 Culturing live bacteria 
 
The E. coli colony was inoculated from LB plate into 2 ml LB broth. It was incubated at 37
0
C 
in a shaking incubator until it reached exponential growth phase which was estimated to be 
around 0.3 at OD650. Bacterial cells were spun down at 5000 x g for 5 minutes. The 
supernatant was discarded and the pellet was re-suspended in 1 ml Buffer A with an 
estimated cell concentration of ~4 x 10
5 
CFU/ml. The same methods used above were also 
employed for M. luteus as a representative of Gram-positive bacteria, except the growth 
temperature of 30
0
C instead of 37
0
C was used to incubate M. luteus, and tryptic soy broth 
was used to culture M. luteus.  
 
2.2.1.3 Cell line maintenance, culture and treatment 
 
SAEIE08 was maintained and stored at -80
0
C in Grace’s media containing 20 % Glycerol. 
For cell culture, SAEIE08 (100 cells/ml) was added to 50 ml Grace’s media and incubated for 
15 hours at 25
0
C. Cell concentration was estimated to be around 6 x 10
6 
cells/ml following 
incubation.  It was then treated with 2 µl heat-killed E. coli of 4 x 10
5 
CFU/ml. Treatment 
was carried out at various hours in order to study differential protein expression patterns 
influenced by hour(s) of treatment with heat-killed E. coli. Controls were not treated with 
heat-killed E. coli. At the appropriate hour(s) of treatment, cultures were spun down at 5000 x 
g for 10 minutes to prepare beetle cell supernatant. Collected SAEIE08 supernatant was 
serially diluted with Buffer B according to table 2.1 below. 
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2.2.2. Liquid media growth inhibition assay 
 
Table 2.1: Liquid growth inhibition assay 
 
 Grace’s 
media 
Undiluted 
Supernatant 
2X diluted 
Supernatant 
4X diluted 
supernatant 
8X diluted 
supernatant 
E.coli 
(Blank 
=Buffer A) 
1. 760 µl 800 µl    40 µl 
2. 760 µl  800 µl   40 µl 
3. 760 µl   800 µl  40 µl 
4. 760 µl    800 µl 40 µl 
5. 1560 µl     40 µl 
 
For assay of bacterial activity, preparations in table 2.1 were incubated at 37
0
C on a shaking 
incubator at 1 hour intervals. After each hour of incubation the OD650 of E.coli were 
measured and recorded for construction of curves illustrating the relationship between rates 
of bacterial growth inhibition upon treatment with different concentrations of SAEIE08 in 
order to study its antimicrobial activity. For the negative control curve, phosphate buffer was 
added instead of SAEIE08.   
 
2.2.3 Protein extraction 
 
SAEIE08 was cultured as previously described to a concentration of 6 x 10
6 
cells/ml. 
Cultured cell line was treated with 10 µl heat-killed E. coli (4 x 10
6 
CFU/ml) for 2 hours and 
then it was centrifuged at 5000 x g for 10 minutes. The resultant sample pellet and 
supernatant were used differently for protein extraction. Sample pellet was collected for 
protein extraction using TRI-reagent from Sigma-Aldrich (catalogue number: T9424) 
following the manufacture’s protocol. Sample supernatant which constitutes the crude extract 
was used for protein concentration and subsequent TCA precipitation. Ultrafree-CL 
centrifugal devices were used for protein concentration followed by precipitation by 20% 
TCA. The resulting pellets from protein extraction and TCA precipitation were re-suspended 
in 125 µl rehydration buffer. The Bradford assay and UV-Vis spectrophotometer were used 
to determine protein concentration. Resulting concentration values were used to calculate 
appropriate volumes to load into SDS-PAGE in order for each well to contain equal protein 
concentration. 
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Figure 2.1: Standard curve for the determination of protein concentration using the Bradford assay. 
The curve consisted of 10 replicates. The mean values were entered into the spectrophotometer and 
this was used as the actual curve. The curve’s equation is given as y= 0.2956x – 0.00004 and R2 = 
0.9994. The curve was constructed according to Hull (2012). 
  
2.2.4 One Dimensional SDS-PAGE analysis 
  
The SDS polyacrylamide gels were run according to Laemmli (1970). Preparations of gels 
were 16% separating gel and 4% stacking gel. The sample was mixed at a ratio of 4:1 with 
sample loading buffer and heated to 95
0
C for 5 minutes before loading. A sample volume of 
20 µl was loaded into each well. Gels were run at a constant voltage of 150 V. The 
electrophoresis run was terminated when the tracking dye reached ~1 cm above the sealing 
part of the gel cast. 
 
After the Electrophoresis run, gels were incubated overnight in coomasie staining solution at 
room temperature on a shaker. Following incubation, gels were washed repeatedly with 
distilled water over 3 hours. They were then destained for 4 hours with coomasie destaining 
solution on a shaker. Distilled water was used repeatedly to rinse gels for 3 hours. 
Alternatively, silver staining was used for sensitive detection of proteins separated by 1D and 
2D SDS-PAGE with detection limits from 0.5-5 ng. An improved silver staining protocol was 
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used according to publication by Mortz, et al. (2001). Gels were sensitized in 0.02% sodium 
thiosulphate for 1 minute followed by washing twice in distilled water for 20 seconds. The 
gels were then incubated in silver staining solution for 20 minutes at 4
0
C. They were 
subsequently washed three times in distilled water for 1 minute, and then placed inside a 
developing solution for 20 minutes in the dark. As the gels turned yellow, staining was 
terminated in 5% acetic acid for 5 minutes. A PDQuest 2-D analysis software version 6.2 
(Bio Rad Cat #170-9630) was used to scan and upload the gel images. 
 
2.2.5 Solid media growth inhibition assay: Agarose overlay method 
 
A single E. coli colony was collected from stock petri dish with a loop and inoculated in 2 ml 
LB broth for culture at 37
0
C until it grew up to 0.3 at OD650. Bacterial culture of 10 µl was 
pipetted into 10 ml sloppy agar (0.5% agar) kept at a temperature of 50
0
C. The mixture was 
shaken vigorously for a few seconds to mix thoroughly then it was poured onto agar plate 
(1.5% agar) containing cut SDS-PAGE gel. Experiment agar plate contained a gel run with 
extracted peptides from SAEIE08. A gel run with markers and SDS sample loading buffer was 
placed on the negative control agar plate. The positive control agar plate was spread with 
0.1% ampicillin in the inner circle of the petri dish. The preparation was incubated overnight 
at 37
0
C. The following day growth inhibition was analysed on agar plates.  
 
2.2.6 2-D PAGE analysis 
 
ReadyPrep 2D Starter (Catalogue number 163-2105) was used to separate protein extracts 
obtained from Tri-reagent extraction and the concentrated protein that was TCA precipitated.  
The kit allows successful separation of protein extract by Two-Dimensional Polyacrylamide 
Gel Electrophoresis using IPG strips and the Bio-Rad PROTEAN IEF cell. The ReadyPrep 
2D starter kit includes all reagents required to rehydrate IPG strips with sample, equilibrate 
IPG strips for SDS-PAGE, and overlay IPG strips with agarose on SDS-PAGE gels. The 
following sub-sections describe an overview of the main steps in 2-D PAGE. The ReadyPrep 
2D Starter kit provides a detailed manual for the 2-D PAGE method. Cell culture and protein 
extraction were performed as previously mentioned. The Bradford assay was also performed 
in order to determine appropriate loading concentrations on the 1
st
 dimension 2-D PAGE.   
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Rehydration 
 
A strip length of 7 cm was used for protein sample re-suspended in rehydration buffer. 
Calculated volumes of re-suspended samples determined by the Bradford assay were pipetted 
as lines along the back edge of channels on the rehydration tray.  Forceps were used to peel 
the coversheet from IPG strips. Strip gels were gently placed gel side down onto samples on 
the channel.  Each strip was overlayed with 3 ml mineral water to prevent evaporation during 
rehydration process. The tray was covered with plastic lid provided and then left on a level 
bench overnight. 
 
Isoelectric focusing 
 
Paper wicks were placed at both ends of the focusing tray channels covering the wire 
electrodes. Nanopure water (8 µl) was pipetted onto each paper wick. IPG strips were 
removed from the rehydration tray using forceps, and then they were transferred to the 
focusing tray. Gels were maintained gel side down then mineral oil (3 ml) was poured onto 
each channel to cover the IPG strip. The focusing tray was covered and placed in a 
PROTEAN IEF cell, which was programmed using the appropriate 3-step protocol depicted 
on the table below. The default cell temperature of 20
0
C was used with a maximum current of 
50 µA/strip and with no rehydration because the rehydration step had been performed. 
 
Table 2.2: PROTEAN IEF cell program consisting of the 3-step protocol 
 
7cm Voltage  Time  Volt-hours Ramp 
Step 1 250 20 minutes 0.25 V-h Linear 
Step 2  4000 2 hours 1000 V-h Linear  
Step 3 4000 3 hours 10 000 V-h Rapid  
Total  8250 6 hours 14 000 V-h  
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Equilibration 
 
Upon completion of the IEF run, IPG strips were removed from the focusing tray and 
transferred gel side up into a clean equilibration tray. Equilibration buffer I (4 ml) was added 
to each channel containing an IPG strip. The tray was gently shaken on an orbital shaker for 
10 minutes. Equilibration buffer I was then discarded and replaced by 4 ml Equilibration 
buffer II into each channel which was also gently shaken for 10 minutes on an orbital shaker. 
Equilibration buffer II was also discarded after shaking, and IPG strips were ready for SDS-
PAGE. 
 
2-D PAGE 
 
SDS-PAGE that is followed by isoelectric focusing differs slightly from normal SDS-PAGE 
due to the use of IPG strips. System setup for SDS-PAGE involved assembling gel cassettes 
and plates, placing gels in the tank and filling the tank with running buffer. An electrode filter 
paper wick was inserted onto the SDS-PAGE gel on the paper wick well, and 10 µl of protein 
marker was pipetted onto the paper wick. IPG strips were removed from the equilibration tray 
and dipped briefly into a graduated cylinder containing 1x Tris/Glycine/SDS running buffer. 
Each gel strip was laid gel side up and onto the back plate of the SDS-PAGE gel above the 
IPG well next to the paper wick well. Forceps were used to carefully push the strip into the 
well while taking care not to introduce bubbles. Overlay agarose solution was poured on the 
IPG and paper wick wells of the gel and allowed to solidify for 5 minutes. Gels were run for 
approximately 2 hours at a voltage of 150 V, and subsequently, they were coomasie- and 
silver-stained for higher gel resolution. Staining and analysis of gels were done as previously 
described. 
 
2.2.7 Extraction of RNA 
 
RNA was extracted from SAEIE08 using the TRI Reagent kit from Sigma-Aldrich 
(Catalogue number T9424) according to manufacturer’s instructions. The TRI reagent is a 
quick and convenient reagent for use in the simultaneous isolation of RNA, DNA, and 
protein. This procedure is an improvement of the single-step method reported by 
Chomczynski and Sacchi, (1987) for total RNA isolation. TRI Reagent performs well with 
large or small amounts of tissue or cells and many samples can be simultaneously extracted. 
This reagent is a mixture of guanidine thiocyanate and phenol in a monophase solution. 
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Guanidium thiocyanate is one of the most effective protein denaturants. SAEIE08 was 
cultured as previously mentioned to a concentration of 6 x 10
6 
cells/ml. It was spun down at 
12 000 x g for 10 minutes. The supernatant was discarded and the pellet was re-suspended in 
1 ml tri-reagent. DNA, RNA, and protein were effectively dissolved on lysis of the pellet. 
After adding chloroform and centrifuging, the mixture separated into 3 phases: an aqueous 
phase containing RNA, interphase containing DNA, and an organic phase containing 
proteins. Each component was then isolated and the RNA aqueous phase was mixed with 2-
propanol followed by centrifugation. The resulting RNA pellet was re-suspended in 75% 
ethanol. After a few centrifugation steps and drying of pellet, RNA pellet was re-constituted 
in distilled water. The RNA concentration and purity were determined by a Nanodrop, and 
analyzed using agarose gel electrophoresis. 
 
2.2.8 Agarose gel electrophoresis 
 
Agarose gel electrophoresis is a standard method used to characterize RNA and DNA in the 
range 200 to 50 000 base pairs (50 kb). Agarose is a linear polymer of galactopyranose 
derivatives (Boyer, 2006). Gels were prepared by dissolving 1% agarose and 5 µl of 10 µg/ml 
ethidium bromide in warm 1x TAE electrophoresis buffer. After cooling the gel mixture to 
50
0
C, the agarose solution was poured on a casting tray and a comb was inserted 
appropriately. RNA sample was prepared in 6x loading dye containing 30% glycerol and 
traces of bromophenol blue, then it was incubated at 65
0
C for 4 minutes followed by cooling 
on ice. The comb was removed from set gel and the gel was placed in an electrophoresis tank 
which was poured with 1x TAE running buffer. RNA sample was then loaded in a sample 
well made with a comb and voltage of 67 V was applied until separation was complete. 
Ethidium bromide allows visualization of separated nucleic acids after electrophoresis. 
 
2.2.9 5′/3′ RACE Technique  
 
RACE stands for Rapid Amplification of (either 5′ or 3′) cDNA ends.  The 5′/3′ RACE kit, 
2
nd
 Generation from Roche (Catalogue number 03353621001) was used to clone the full 
length transcripts from trizol extracted RNA following the manufacturer’s instructions. 5′ 
RACE allows the amplification of unknown sequences at the 5′ end of the mRNA, whilst 3′ 
RACE amplifies sequences at the 3′ end of the mRNA.  
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First strand 5′ cDNA was synthesized from total mRNA using primers that were constructed 
from immune response genes such as hopscotch, defensin, and apolipoprotein and the 
enzyme transcriptor reverse transcriptase. The protocol provided in the kit was used for the 
rapid amplification of the 5′ cDNA end. PCR reactions were performed according to the 
following conditions: 2 minute initial denaturation at 94
0
C; 35 cycles of denaturation, 
annealing and elongation at 94
0
 for 15 seconds, 55
0
C for 30 seconds, and 72
0
C for 40 
seconds, respectively; and final elongation at 72
0
C for 7 minutes. The High Pure PCR 
product Purification Kit from Roche (Catalogue number 11732676001) was used to purify 
the 5′ cDNA product. Purified 5′ cDNA was poly(A)-tailed with dATP and TdT and then 
amplified via the Polymerase Chain Reaction (PCR) following manufacturer’s instructions.  
 
 
Figure 2.2: Overview of the 5′ RACE method from manufacturer’s protocol.  
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For amplification of the 3′ cDNA end, the 3′ RACE protocol takes advantage of the natural 
poly(A)-tail of mRNAs as a priming site for PCR amplification. First strand 3′ cDNA 
synthesis is initiated at the poly(A)-tail of mRNA using transcriptor reverse transcriptase and 
the oligio(dT)-Anchor primer. After converting mRNA into cDNA, amplification is then 
performed without a further purification step using the PCR Anchor primer and the hopscotch 
primer. The thermal cycle profile used for 3′ cDNA end was as follows: Initial denaturation at 
94
0
C for 3 minutes; 40 cycles of denaturation, annealing and elongation at 94
0
C for 30 
seconds, 60
0
C for 30 seconds, and 72
0
C for 1 minute, respectively; final elongation at 72
0
C 
for 7 minutes. 
 
 
 
Figure 2.3: Overview of the 3′ RACE method from manufacturer’s protocol. 
 
The concentration and purity of the PCR products from the 5′ cDNA and 3′ cDNA strands 
were determined by use of a Nanodrop and analyzed via Agarose gel electrophoresis. At this 
stage they were ready for cloning procedures. 
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2.2.10 Cloning of genes 
 
The PCR products were ligated to the pGEM – T Easy vector following manufacturer’s 
instructions of the pGEM – T Easy vector cloning system (See appendix 2 for the pGEM – T 
Easy vector on page 57). The ligation reaction was set-up according to the manufacture’s 
protocol. The reaction was incubated for 12 hours at 4
o
C and inactivated by incubating at -
70
o
C for 15 minutes.  
  
Transformation  
 
Competent cells, E. cloni, were kept on ice for 20 minutes before use. A ligation reaction of 4 
µl was added to 40 µl frozen competent cells and the mixture was placed on ice for 20 
minutes. Thereafter, it was heat-shocked for 45-50 seconds at 42
0
C. SOC media of 960 µl 
was added and incubated at 37
0
C for 1.5 hours. Plates for Blue/white selection were prepared 
by adding 100 µl of 100 mM IPTG to 20 µl of 50 mg/ml X-gal and spreading across LB 
plates. After 30 minutes incubation of LB plates, 100 µl of transformation culture was plated 
onto LB/ampicillin/IPTG/X-gal plates, which were incubated overnight at 37
0
C. The 
following day, blue and white colonies were counted on each plate and transformation 
efficiency was calculated. 
Colony screening 
  
A white colony was inoculated from LB/ampicillin/IPTG/X-gal plate and cultured in 2 ml LB 
broth overnight in order to extract Plasmid DNA using the QIAprep Spin Miniprep kit from 
Qiagen (Catalogue number 27106). Overnight culture was pelleted by centrifuging at 6000 x 
g for 5 minutes at room temperature. Buffer P2 from the kit was used to lyse cells for release 
of plasmid DNA. The QIAprep spin columns plus specific buffers from the kit were used to 
purify Plasmid DNA. Concentration and purity of collected Plasmid DNA was measured by a 
Nanodrop. Restriction enzyme digestion was carried out using EcoR1 and 10x EcoR1 buffer 
to cleave Plasmid DNA in order to release DNA inserts. The reaction was incubated 
overnight at 37
0
C. The presence and size of DNA inserts were confirmed by analysis using 
agarose gel electrophoresis.   
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Colony PCR and sequencing of DNA 
 
Plasmids with DNA inserts were sent to Inqaba Biotechnical Industries (Pty) Ltd where they 
were sequenced using standard forward and reverse M13 Primers, which bind to either side 
of the multiple cloning sites in the pGEM – T Easy vector. Resulting sequences were 
processed manually using bioinformatics before being submitted for database searches. 
Finally, BLAST searches were carried out using the NCBI database.  
 
2.2.11 Isolation and identification of antimicrobial peptides 
 
SAEIE08 cell culture and treatment were done as previously mentioned. Protein was 
extracted from SAEIE08 using the TRI Reagent kit from Sigma-Aldrich (Catalogue number 
T9424) according to manufacturer’s instructions. One dimensional SDS-PAGE was 
performed to check for protein purity and integrity. E. coli treated and untreated samples 
were sent to the CSIR for protein sequencing. For protein sequencing, each of the E. coli 
treated and untreated lanes of the SDS-PAGE gel were used. The bands from each lane were 
excised and divided into fractions which were digested using an endoprotease. The resulting 
solution was passed through a mass spectrometer (LC-MS/MS) which produced peptide 
fragments and measured their mass-charge ratios. The mass spectrum was analyzed using 
searches against specific databases of Coleoptera (Tribolium casteneum) and Diptera 
(Drosophila melanogaster) and also against the Uniprot and Swissprot databases. 
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Chapter 3: Results 
 
This chapter utilizes the same order of presentation used in methodology in that the first two 
sections, 3.1 and 3.2, show immune response of SAEIE08 upon exposure to pathogen. These 
sections consist of graphs from liquid inhibition assays with associated tables and statistics, 
supported by solid inhibition assays, all indicating the presence of secreted antimicrobial 
activity.  The section is followed by observation of protein expression patterns upon exposure 
of SAEIE08 to heat-killed E. coli. This particular section has data comprised of SDS-PAGE 
and 2-D PAGE gels implicating the presence of antimicrobial peptides around 10 kDa (and 
high molecular weight proteins that may be involved in immunity). The last section (3.3) 
presents sequencing data from the 5′/3′ RACE kit and Molecular Biology techniques, which 
were analysed by bioinformatics and tools such as NBLAST and XBLAST searches on the 
NCBI database.   
 
3.1 Assay of antimicrobial activity  
3.1.1 Liquid Growth inhibition assay 
 
The major aim of this part of the study was to analyze the immune response of SAEIE08 
upon exposure to pathogens, specifically Escherichia coli and Micrococcus luteus, with the 
intention to show inducible and constitutive antimicrobial activity. SAEIE08 was treated with 
heat-killed E. coli, and then used as a growth inhibitor for live bacteria whose growth was 
measured at OD650. The culture medium of SAEIE08 was diluted to compare differences in 
bacterial growth inhibition by least to most diluted SAEIE08 culture medium. In order to 
quantify the level of antimicrobial activity in the undiluted and differentially diluted 
SAEIE08, the negative control was used as a reference point for calculations of bacterial 
growth inhibition percentages. As anticipated, inducible and constitutive antimicrobial 
activities were observed in figure 3.1. In figure 3.1 A (treated) and B (untreated), there was a 
small difference in rates of bacterial growth, as it increased slightly faster for B (untreated) 
than A (treated), with the exception of the negative control curves (no cell line added), which 
had approximately the same growth rates in both A and B. For example, in the undiluted 
SAEIE08, at 240 minutes of incubation the higher reading of 0.353 is that of E. coli in 
untreated control, whilst E. coli in treated SAEIE08 is slightly lower at 0.339. In all dilutions, 
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the OD650 readings in A had slightly lower values compared to B. Furthermore, table 3.1 
shows that maximum E. coli growth inhibition was observed for the 3 hour-treated and 
undiluted SAEIE08 at 36.4%. On the contrary, the lowest growth inhibition was 16.7% of the 
undiluted and 3 hour-untreated control. Therefore, it is evident that treated cell line shows 
inducible antimicrobial activity while the activity in untreated cell line may be constitutive.  
 
In treated SAEIE08 and their untreated controls, an increase in bacterial growth is not always 
proportional to hours of SAEIE08 treatment. An example can be observed in figure 3.2 by 
comparing the 1 hour- and 3 hour-treated SAEIE08. Lower E. coli growth of 0.025 at OD650 
(SD of 0.015) was initially observed at 60 minutes of incubation for the 1 hour-treated 
SAEIE08  compared to the 3 hour-treated SAEIE08  at OD650 reading which was higher at 
0.033 (SD of 0.030). In contrast, at 300 minutes of incubation, bacterial growth of 0.388 (SD 
of 0.066) in the 1 hour-treated SAEIE08 seemed to increase comparably well to growth in the 
3 hour-treated SAEIE08 which was 0.388 (SD of 0.024). Table 3.2 provides further evidence 
in that the 1 hour treatment caused a high level of inhibition more than the 2 hour- and 3 
hour-treatments. Therefore, level of inhibition is not dependent on hours of treatment. The 
inhibition assay that was performed with M. luteus did not produce normal growth curves. 
However, a pattern of growth inhibition could still be observed from least to most diluted cell 
line. The undiluted SAEIE08 appeared to have a stronger inhibitory effect on bacterial 
growth compared to all dilutions.  
 
 
Figure 3.1: Liquid growth inhibition assay showing E. coli optical density when cultured in different 
dilutions of SAEIE08 that was: A. treated with heat-killed E. coli for 3 hours, and B. untreated with 
heat-killed E. coli (control). The study was repeated four times in triplicate from which the mean and 
standard deviation were determined.  
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Table 3.1: Comparison of growth inhibition percentage between the 3 hour-treated SAEIE08 
and the untreated control at 300 minutes of E. coli growth. 
 
Cell line dilutions 3 hour-treated inhibition % Untreated control  inhibition 
% 
Undiluted 36.4 16.7 
2X diluted 29.7 23.1 
4X diluted 24.2 21.9 
8X diluted 23.3 18.9 
 
 
Figure 3.2: E. coli growth observed when cultured in undiluted SAEIE08  treated (A) and untreated 
(B) with heat-killed E. coli for 1, 2 and 3 hours. The error bars represent the standard error of the 
means of biological replicates. The study was repeated four times in triplicate.  
Table 3.2: E. coli growth inhibition percentage when cultured in differentially diluted 
SAEIE08 that was treated at different hours with heat-killed E. coli. 
 
E. coli growth Inhibition % in undiluted and differentially diluted SAEIE08 
Treatment hours   Undiluted  2X diluted  4X diluted  8X diluted  
1 hour  38.6% 33.6% 25.3% 23.3% 
2 hours  35.9% 28.8% 26.5% 23.5% 
3 hours  36.4% 29.7% 24.2% 23.3% 
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Figure 3.3: Liquid growth inhibition assay showing M. luteus optical density in different dilutions of 
SAEIE08. In order to determine the mean and standard deviation, the study was done in 
triplicate and repeated three times.  
 
3.1.2 Solid growth inhibition assay 
 
The solid media growth inhibition assay was performed with the intention to show bacterial 
growth inhibition as a result of induced antimicrobial activity in SAEIE08. The complete 
method required use of three techniques: firstly, proteins were extracted from treated 
SAEIE08 crude extracts; secondly, protein extracts were run on an SDS-PAGE gel; and 
lastly, the agarose overlay method was performed using the SDS-PAGE gel containing 
protein extract which was placed on an LB plate and poured with live E. coli mixed with soft 
agar and then left overnight to incubate at 37
0
C. The method outcome can be seen in figure 
3.4 that shows evidence for growth inhibition. Plate A contains a gel run with protein extracts 
from SAEIE08. There was significantly higher E. coli growth inhibition on the gel overall, 
even though the most visible peptide bands were only at the bottom part of the gel. Plate B 
had a gel with protein markers and SDS sample loading buffer as a negative control. E. coli 
growth colonies were visible all over the LB plate and on the negative control gel. There 
appeared to be no inhibition of growth by protein markers and sample loading buffer. Plate C 
was spread with ampicillin to act as a positive control at the central part of the plate by 
inhibiting bacterial growth on this region which showed a clear zone of growth inhibition. 
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Figure 3.4: LB plates of the agarose overlay method. Plate A is the test plate with an SDS-PAGE gel 
run with peptides, the gel in Plate B contains protein markers as the negative control and Plate C has 
ampicillin as a positive control. The study was done in duplicate and repeated twice.  
 
3.2 Analysis of differential protein expression in E. intermedius upon 
exposure to heat-killed E. coli. 
 
The induced antimicrobial activity was suspected to be caused by antimicrobial peptides with 
molecular weights below 10 kDa. Therefore, bands and spots on SDS-PAGE and 2-D PAGE 
gels, respectively, were expected to have sizes that are less than 10 kDa. These techniques 
were also done to show the difference of induced peptides between treated and untreated cell 
line at various hours. In order to analyse protein expression patterns, SAEIE08 was cultured 
overnight, then it was treated with heat-killed E. coli for 1, 2 or 3 hours. Protein was 
subsequently extracted from the lysed treated and untreated control by Trizol extraction. 
Extracted protein was run on SDS-PAGE and 2-D PAGE in order to analyse differences in 
expressed protein patterns between SAEIE08 treated at different hours and their respective 
untreated controls.  
 
Figure 3.5 A shows results obtained from running a coomasie blue stained SDS-PAGE gel, 
while the gel in figure 3.5 B was cypro stained by Dr. Stoyan Stoychev from the CSIR. The 
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cypro-stained gel revealed many proteins that were not visible in the coomasie blue stained 
gel. These pointed proteins were sent for identification by MS spectrometry, but 
unfortunately at the time of submission the results had not yet arrived.  2-D PAGE gels in 
figure 3.6 are presented in A, B, C and D.  
 
Low molecular weight bands and spots implicating the presence of antimicrobial peptides 
were observed. The most intense bands in gel A of figure 3.5 were seen at 10 kDa and 16 
kDa (marked with red circles). Furthermore, gel A and B of figure 3.6 had similar spots 
circled with red at the low molecular end of the gel (~10 kDa). However, gel A had two more 
spots around 10 kDa (white circles) that were not found in gel B, which provides evidence for 
differential protein expression patterns between the treated and untreated cell line.   
 
Differential protein expression was evident in Gel A of figure 3.5 which showed that the 3 
hour- and 2 hour-treated SAEIE08 had the highest band intensities which may have been due 
to AMP induction upon treatment of SAEIE08 with heat-killed E. coli. The untreated control 
lane showed the least intense bands overall. Gel B also indicated a difference in band 
intensity between the 3 hour-treated and untreated control. Furthermore, some bands were 
only present in the 3 hour-treated lane and absent in the untreated control lane, such bands are 
pointed in Gel B (red pointer), implicating that differential protein expression occurred. In 
addition, figure 3.6 of 2-D PAGE gels shows that A had fewer spots than its untreated 
control, B, but it had higher intensity than the untreated control.  Gel C of figure 3.6 showed 
uneven migration which may have resulted from poor heat transfer caused by air bubbles 
under the second-dimension gel.  
 
A second approach for analysis of protein expression patterns employed a method that did not 
require protein extraction. Cultured cell line was treated with heat-killed E. coli and then the 
supernatant was collected for concentration and TCA precipitation, which was eventually 
analysed via 2-D PAGE. 2-D PAGE results produced blank gels (or gels with smaller and 
lighter spots) that only showed markers clearly (See appendix 3 on page 58), indicating 
absence of protein which may have been due to very low protein concentration in the crude 
extract as a result of the sample concentration method applied.  
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Figure 3.5: Two SDS-PAGE gels run with trizol extracted proteins from SAEIE08 that was treated or 
untreated with heat-killed E. coli. (A) Silver stained gel and (B) Cypro-stained gel (The cypro-stained 
gel was run by Dr. Stoychev from the CSIR). A red pointer was used for bands that were present only 
in the treated cell line. Both red and black pointed bands were sent for sequencing. 
 
 
 
Figure 3.6: 2-D PAGE gels of trizol extracted proteins from SAEIE08 that was treated or untreated 
with heat-killed E. coli. Silver-stained gel A is the 1 hour-treated SAEIE08 and its untreated control is 
B. Coomasie-stained gel C is the 2 hour-treated SAEIE08 and D is the untreated control. Spots that 
were circled with a red color were found in both the treated SAEIE08 and its untreated control. 
White-circled spots were found in only one of the two gels, either the treated or untreated SAEIE08.  
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3.3 The isolation and identification of genes that code for antimicrobial 
peptides in SAEIE08. 
 
The aim of this study was to produce genes that can encode putative antimicrobial peptides. 
The RNA in figure 3.7 A was extracted from SAEIE08 using the TRI Reagent kit. RNA 
concentration and purity were determined by Nanodrop to be 1532.5 ng/µl with purity level 
of 260/280 ratio at 1.95. The RNA was reverse transcribed and amplified using the defensin 
(def), apolipoprotein (Apolll) and hopscotch (Hop27me) reverse primers. These primers were 
sequenced from isolated immune-response genes which are the defensin, hopscotch and 
apolipoprotein by previous studies. However, only the hopscotch primer produced PCR 
products with sizes of 1000 bp and 300 bp as can be seen in figure 3.7 B. The PCR products 
were subsequently cloned into the pGEM – T easy vector. Plasmids with DNA inserts were 
sent to Inqaba biotechnical Industries (Pty) Ltd for sequencing by use of standard M13 
forward and reverse Primers. Forward and reverse sequences of the 3′ RACE and 5′ RACE 
inserts were processed manually and aligned using bioinformatics to form short sequences 
(See appendix 59 for sequences) which were subsequently searched for matches using 
NBLAST and XBLAST on the NCBI database. Table 3.4 shows that sequences obtained 
from the RACE technique unexpectedly matched to homologues of Saccharomyces 
cerevisiae proteins that have roles in metabolism, molecular pathways and/or cell 
proliferation. The sequence identities are very high, varying between 91-100%, while E-
values are low. The Spodoptera frugiperda mRNA for allatotropin (100% identity) is the only 
insect gene identified. 
  
Figure 3.7:  RNA extraction and 5′ RACE gels obtained using agarose gel electrophoresis. (A) 
Extracted RNA gel with RNA at 1000 bp and 1400 bp. (B) Three PCR products amplified with 
different primers. The hopscotch primer produced PCR products of ~1000 bp and ~300 bp. 
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Table 3.3: Transformation using the pGEM – T Easy vector ligation reactions 
 
Plate White colonies Blue colonies 
pUC 18 41 395 
Standard reaction (SR) 124 288 
Positive reaction (PC) 8 23 
Background control (BC) 1 22 
BC without ampicillin Lawn of colonies 0 
 
Purified PCR products were ligated to the pGEM – T Easy vector using the pGEM – T Easy 
vector cloning system, followed by transformation using E. cloni cells. Blue/white selection 
was performed and blue and white colonies were counted on each plate as recorded in table 
3.3. The test plate had 124 white colonies (vectors and inserts ligated) and 288 blue colonies 
(vectors and inserts not ligated). Transformation efficiency was calculated as follows: 124 
cfu/0.001 ng = 1.24 x 10
5 
cfu/ng = 1.24 x 10
8
 cfu/μg DNA  (Transformation efficiency has to 
be greater than 1 x 10
8 cfu/μg DNA in order to continue to subsequent steps. Therefore, the 
obtained value of 1.24 x 10
8
 cfu/μg DNA was sufficient).   
 
 
Figure 3.8: Digested Plasmid DNA for release of DNA inserts. The figure depicts three plasmid 
DNAs (~4000 bp) before digestion plus three DNA inserts (two 1000 bp and one 750 bp) released 
after digestion. 
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Table 3.4: Proteins from the NCBI XBLAST search of 5′/3′ RACE sequences  
 
XBLAST  Sequence 1  Sequence 2 Sequence 3 Sequence 4 Sequence 5 
(NBLAST) 
Organism  S. cerevisiae 
EC1118  
S. cerevisiae 
S288c  
S. cerevisiae 
S288c  
S. cerevisiae 
EC1118 
S. frugiperda  
Protein Identity  Flavin-
containing 
monooxyginase 
(FMO) 
Long chain fatty 
acyl-CoA 
synthetase 
severe 
depolymerizatio
n of actin 
protein 1 
(SDA1p) 
Serine/threonine 
protein kinase 
MRK1p 
mRNA for 
allatotropin  
NCBI Accession 
number 
CAY80188.1 EDN63641.1 EDZ71913.1 CAY78430.1 AJ508907.1 
Identity  100% 98% 99% 91% 100% 
E value 4x10
-136 
2 x10
-73
 6 x10
-87 
2 x10
-33 
1 x 10
-33 
Query coverage 78% 48% 50% 37% 8% 
Nucleotide seq. 1043bp 781bp 1124bp 1009bp (13 residues) 
Conserved 
domains 
*flavin-
containing 
monooxygenase 
[PLNO2172]   
 
* Long-chain 
acyl-CoA 
synthetases 
[COG1022] 
*SDA1 
[pfam05285]; 
family consists 
of SDA1 protein 
homologues 
*Glycogen 
synthase kinase 
[PTZ00036] 
*Glutamate 
dehydrogenase 
[PTZ00324] 
No domains 
Function Involved in K
+
 
transport and 
metabolism 
Lipid 
metabolism 
 
Involved in 
organization of 
the actin 
cytoskeleton 
Key regulator of 
molecular 
pathways 
Involved in 
regulation of 
growth and 
reproduction 
 
Table 3.4 shows sequences in the NCBI database that matched the query sequences obtained 
from cloning of genes that were amplified using the 5′/3′ RACE Technique. Many of them 
are Saccharomyces cerevisiae homologues. These proteins are flavin-containing 
monooxygenase, fatty acyl-CoA synthetase, serine/threonine protein kinase and severe 
depolymerization of actin protein. They have been reported to play roles in metabolism, cell 
proliferation and/or molecular pathways. The only match to an insect peptide is allatotropin 
from Spodoptera frugiperda. 
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Chapter 4: Discussion 
 
In the study of SAEIE08 response upon exposure to E. coli, both inducible and constitutive 
antimicrobial activity was secreted into the supernatant by cell line. Bacterial growth 
inhibition, tested by E. coli, was highest in the 1 hour-treated and undiluted SAEIE08, and 
longer treatment of SAEIE08 with heat-killed E. coli did not induce higher antimicrobial 
activity. Unidentified molecules with sizes around 10 kDa and 16 kDa were seen and some 
were cationic while others were anionic or neutral. Some higher molecular weight proteins of 
around 130 kDa were up-regulated upon treatment of cell line with heat-killed E coli. 
Abnormal growth curves were observed when samples were tested by M. luteus, which 
represents Gram-positive bacteria. Of the genes identified, the closest to AMPs was insect 
gene for allatotropin. The protein encoded by this gene has homologues in Spodoptera 
frugiperda (armyworm). Homologues of Saccharomyces cerevisiae proteins were found that 
could indicate some contamination or could be as a result of inaccuracies from using short 
sequences to search for matches in the NCBI database. Interestingly, these proteins play roles 
in metabolism, cell proliferation and/or molecular pathways which do occur when cells are 
exposed to stress.  
 
4.1 Activation of immunity by Gram-negative bacteria 
 
4.1.1 Inducible and constitutive antimicrobial activity 
 
The study shows the presence of inducible and constitutive antimicrobial activity in 
antimicrobial assays. PAGE techniques also show high molecular weight and low molecular 
weight proteins that are up-regulated upon treatment of SAEIE08 with heat-killed E. coli. 
Although bacterial growth was not completely inhibited in liquid inhibition assay, it 
decreased significantly enough to suggest the presence of antimicrobial activity in SAEIE08. 
The evidence of antimicrobial activity even in untreated SAEIE08 may be explained by 
constitutive release of antimicrobial molecules in SAEIE08 (Chalk, et al. 1993). As 
previously mentioned, the antimicrobial molecules that are constitutively released are initially 
stored in haemocytes, and they are only released into the hemolymph after immune 
challenge. Therefore, antimicrobial activity observed even in untreated cell line could be as a 
result of stored antimicrobial molecules.  
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Although growth inhibition was generally high in all hours of undiluted treatments, it was 
particularly highest in the 1 hour-treated and undiluted SAEIE08. This indicates that longer 
treatment of SAEIE08 with heat-killed E. coli does not necessarily induce higher 
antimicrobial activity. 
  
4.1.2 Possible up-regulation of low molecular weight peptides 
 
It is interesting to note that the more intense bands on the SDS-PAGE gel have sizes around 
10 kDa and 16 kDa. Their expression was up-regulated in response to treatment with heat-
killed E. coli, which suggests that they may have antimicrobial activity. There is a wealth of 
information on the small size of antimicrobial peptides as it is usually found below 10 kDa 
(Hoffmann, et al. 1996; Bulet, et al. 1999; Reddy, et al. 2004; Teixeira, et al. 2012; Yount, et 
al. 2006; Sovadinova, et al. 2011). There are also antimicrobial polypeptides generally 
reported to have a molecular mass below 30 kDa (Cytrinska, et al. 2007). While some of the 
low molecular weight peptides found in the current study are positively charged, others have 
a negative or neutral charge (2-D PAGE gels). Contrary to the cationic charge of most 
antimicrobial peptides, anionic peptides have been reported as previously mentioned. 
Identification of all the differentially charged low molecular peptides might reveal the 
presence of putative antimicrobial peptides. One of the weaknesses of this part of the study is 
that the 2D gels were conducted on lysed cells due to difficulties encountered with de-salting 
the supernatants. It is expected, based on the antimicrobial assays that most of the peptides 
would be found in the supernatant. 
 
4.1.3 Possible up-regulation of high molecular weight proteins 
 
Page techniques show high molecular weight proteins around 130 kDa that are up-regulated 
upon treatment with heat-killed E. coli. This may suggest the induction of antimicrobial 
polypeptides which have also been reported in literature (Nibbering, et al. 2001; Yount, et al. 
2006). Such polypeptides and proteins considerably larger than classical AMPs have been 
shown to have unambiguous antimicrobial activity. Known examples include the 80 kDa 
lactoferrin (Yount, et al. 2006). However, only a few inducible antibacterial molecules are 
polypeptides larger than 10 kDa (Bowman, 1994). Therefore, an alternative explanation for 
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the up-regulation of larger proteins upon treatment is that even though the proteins may not 
have antimicrobial activity, they could be involved in immune response. Examples are 
peptidoglycan recognition proteins (PGLYRPs) that are variably sized (~20-120 kDa), first 
characterised in insects. These proteins function as pattern recognition receptors that initiate 
downstream immunomodulatory signalling cascades through receptor-linked IMD or Toll 
pathways (Yount, et al. 2006). Identification of proteins in the current study might give 
further insight of the pathways activated by performing bacterial challenge. Based on 
information obtained from previous studies, the likely pathway to be activated by Gram-
negative bacteria in SAEIE08 is the Toll signalling pathway. This pathway was implicated in 
a study by Hull, (2012), of the E. intermedius immune response upon exposure to fungi. 
Furthermore, the Toll signaling pathway was also shown in studies of coleopteran immunity. 
As previously mentioned, larger beetles such as Tenebrio molitor and Holotrichia diomphalia 
contain PAMPs that form complexes with Gram-negative binding protein 3 (GNBP3) in 
fungi and peptidoglycan recognition protein in Gram-negative bacteria, and thereby activate 
the Toll signalling pathway. 
 
4.2 SAEIE08 response to Gram-positive bacteria  
 
The growth curve of liquid growth inhibition assay performed for M. luteus shows optical 
densities that are generally lower than those obtained for E. coli, although the assays were the 
same. The highest optical density obtained for M. luteus does not read above 0.1 at OD650, 
whereas that of E. coli grew well up to 0.5 and above at OD650. However, this does not imply 
that the SAEIE08 has a high growth inhibitory effect on M. luteus compared to E. coli 
because inconsistencies in M. luteus growth rates can be observed across the different 
dilutions and in the negative control that was without the SAEIE08. Such inconsistent growth 
rates were observed in replicates of the experiment. In addition, it was difficult to grow M. 
luteus on LB plates for solid inhibition assays. Therefore, it was concluded that this particular 
strain of M. luteus may have been contaminated. Hence, for subsequent experimentation, it 
could no longer be used.  
 
46 
 
4.3 Proteins identified 
 
4.3.1 Likely discovery of the gene of interest that codes for allatotropin neuropeptide in 
SAEIE08.  
 
The only likely match to an insect gene of interest was the mRNA for allatotropin (sequence 
5 in table 3.4) from the fall armyworm Spodoptera frugiperda, which had 100% sequence 
identity but only 8% query coverage. This sequence was found in most 5′/3′ RACE aligned 
forward and reverse DNA inserts. Allatotropin (AT) is a 13-residue amidated neuropeptide 
that has been characterized in various insect species, and members of the family are present 
in several invertebrate phyla. Neuropeptides are a diverse class of regulatory compounds that 
are released from neurons and they behave as neuromodulators, neurotransmitters or 
neurohormones. Many invertebrates such as insects have the same number and diversity of 
neuropeptides. Neuropeptides perform many roles in different tissues (Elekonich & 
Horodyski, 2003). Allatotropins (AT) and allatostatins (AS) are among the most well-known 
families of insect neuropeptides. The expression pattern of genes for AT and its antagonist, 
AS, are precisely regulated and often regulated under specific physiological conditions 
(Abdel-latief, et al. 2004). Abdel-latief, et al. (2004), studied the expression of AT and AS 
genes, respectively, during larval, pupal and adult development of S. frugiperda. AT and AS 
regulate the biosynthesis and release of the Juvenile hormone (JH) that control growth and 
reproduction. The corpora allata is a small endocrine gland positioned in the head and 
innervated by nerves in the brain. It is responsible for synthesis and release of JH (Veenstra 
& Costes, 1999).  CA is present in all insect stages, and depending upon species and 
development stages, the signals for JH synthesis and release may be either stimulatory (AT) 
or inhibitory (AS). JH is critical for regulation of larval development, metamorphosis and 
reproduction in insects (Abdel-latief, et al. 2004). The following are some of the functions of 
AT (or JH under regulation by AT and AS): AT controls the release of digestive enzymes and 
gut myoactivity in many insects; it is cardioacceleratory in M. sexta; involved in the control 
of ion transport in epithelial cells of the digestive system; controls the release of digestive 
enzymes in the midgut of S. frugiperda; induces peristaltic contractions in the hindgut of T. 
Infestans (Santini & Ronderos, 2009);  involved in the regulation of vitellogenesis in females 
and spermatogenesis in males (Gade, et al. 1997); participates in the modulation of the 
circadian cycle; plays a role in the regulation of nutrient absorption; has an effect on the 
activity of soluble alkaline phosphatases and is associated with ionic balance regulation 
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(Santini & Ronderos, 2009). In 1999, an allatotropin-immunoreactive peptide was discovered 
by Veenstra and Costes in the abdominal ganglia of the mosquito Aedes aegypti. It has also 
been reported that the secretion of neuropeptides can occur simultaneously with the secretion 
of AMPs. Studies by Phoenix, et al. (2013), have shown that a spectrum of AMPs was 
included in skin secretions of anurans that range between 10 and 20 members along with 
other bioactive peptides that include neuropeptides.    
 
  
Figure 4.1: Phylogenic tree of closely related insect orders and phyla that was constructed by use of 
the neighbor joining method from the alignment of ribosomal protein L18a sequences using the 
MUSCLE algorithm (Edgar, 2004).  
 
The tree in figure 4.1 shows the close relation between Euoniticellus intermedius and 
Spodoptera frugiperda which correlates to results in this study. The current study suggests 
that the Spodoptera frugiperda gene that encodes allatotropin has a homologue in embryonic 
Euoniticellus intermedius cell line. 
 
The likely discovery of allatotropin in this study, although unintended, is significant when 
taking into consideration the fact that Coleoptera is one of the insect orders in which there is 
little knowledge about the regulator of JH synthesis and associated peptides (Abdel-latief & 
Hoffmann, 2010). Abdel-latief & Hoffmann, (2010) stated that evidence is lacking on 
neuropeptide regulation of JH biosynthesis in beetles. Furthermore, little is known about E. 
intermedius sequences as the whole genome is yet to be sequenced. Therefore, this finding 
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contributes information to important sequences that are present in E. intermedius and it could 
potentially aid the study of identification and characterization of neuropeptides in E. 
intermedius. 
 
Flavin-containing monooxygenase  
 
Sequence 1 reported in table 3.4 that has 100% identity and query coverage of 78% is a 
homologue of the flavin-containing monooxygenase from Saccharomyces cerevisiae. The 
flavin-containing monooxygenase (FMO) enzymes metabolize xenobiotics. Such enzymes 
have been historically called drug-metabolizing enzymes, although they are involved in the 
metabolism of many foreign chemicals that are potentially harmful to humans and animals. 
FMOs have been implicated in the metabolism of a number of pesticides, pharmaceuticals 
and toxicants (Ziegler, 1980). The FMO protein family consists of a group of enzymes that 
catalyze chemical reactions which involve oxidation of heteroatoms, particularly nucleophilic 
atoms such as the nitrogen of amines, through the bound cofactor flavin. Using an NADPH 
cofactor and FAD prosthetic group, these microsomal proteins catalyze the oxygenation of 
nucleophilic nitrogen, sulphur, phosphorus and selenium atoms in a range of structurally 
diverse compounds. In humans, lack of hepatic FMO-catalyzed trimethylamine metabolism 
results in trimethylaminuria (fish odour syndrome) (Dolphin, et al. 1992; Itagaki, et al. 1996). 
 
Fatty acyl-CoA synthetase 
  
Sequence 2 in table 3.4 represents the long chain fatty acyl-CoA synthetase (FACS), an S. 
cerevisiae homologue, which is required for phospholipid remodeling, fatty acid degradation 
and the production of fatty acyl-CoA that regulates various physiological processes. The 
FACS family consists of at least 25 members that are broadly classified by their substrate 
specificities for fatty acids of different chain lengths. Many questions remain with regards to 
the cellular localization and specific biological functions of the different forms of the FACS 
enzymes (Mashek, et al. 2007). A fatty acid from an endogenous or exogenous source is first 
activated to form an acyl-CoA before it can enter any metabolic pathway (except eicosanoid 
metabolism). FACS plays a significant role in intermediary metabolism through a reaction 
that forms long acyl-CoA esters. The formation of fatty acyl-CoA is catalyzed by FACS in a 
two-step reaction:  
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Acyl-CoAs are bioactive fatty acid metabolites that are involved in enzyme activation, 
protein transport, protein acylation, transcriptional control and cell signalling (Weimar, et al. 
2002; Qiao and Tuohimaa, 2004; Soupene and Kuypers, 2008). According to a review article 
by Mashek, et al. (2007), long-chain acyl-CoAs can alter multiple cellular processes 
including signal transduction via calcium ion release and PKC isoforms. Fatty acids and acyl-
CoAs regulate numerous transcription factors including the NF-ĸβ. As previously mentioned, 
the NF-ĸβ-like transcription factor known as relish, controls the transcription of immune-
related genes in Drosophila melanogaster.  
 
SDA1p 
  
The SDA1 gene encodes a highly conserved protein also known as SDA1 which is localized 
in the nucleus and is important for cell viability (Buscemi, et al. 2000). It has been shown to 
be highly conserved from yeast to humans. The Protein SDA1 is required for correct 
organization of the actin cytoskeleton as reported by Buscemi, et al. (2000). The same study 
also indicated that loss of SDA1 function caused a cell cycle arrest in G1. It is interesting to 
note that the study by Hull, et al. (2013) that aimed to assess the E. intermedius signalling 
pathways, did isolate, among other proteins, gelsolin, which is an actin-binding protein, 
making it a structural component of the cytoskeleton. Gelsolin is found in invertebrates such 
as Drosophila in two splice forms, cytoplasmic and secreted. Interestingly, gelsolin, similar 
to SDA1, is involved in cytoskeletal organization (Stella, et al. 1994). Gelsolin is also 
involved in biogenesis, amyloid formation in vertebrates and hemolymph clotting in insects 
(Karlsson, et al. 2004). 
 
Successful cell proliferation requires coordination of cell cycle events. Serine/threonine 
protein kinases known as cyclin-dependent kinases that were reviewed by Nasmyth, (1993), 
are known to control the correct order of these events. The activity of these kinases oscillates 
during the cell cycle, eventually triggering cytoplasmic and nuclear events. Cell cycle 
progression also has to have numerous morphogenetic events related to actin organization 
which is controlled by SDA1. Actin is a very abundant protein in all eukaryotes. The actin 
cytoskeleton plays a significant role in numerous cellular processes such as cell motility, 
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secretion, polarized cell growth and endocytosis, and including its involvement in cell 
preparation for cytokinesis (Buscemi, et al. 2000).   
  
Serine/threonine protein kinase 
 
Serine/threonine protein kinase, MRK1p, is a protein reported in table 3.4 as sequence 4. 
Protein kinases are known for their ability to catalyze the transfer of a phosphate group from 
a nucleoside triphosphate to the protein substrate’s amino acid residue (Jacob, et al. 2011). 
Protein kinases are key regulators of molecular pathways, and it is estimated that 
approximately 50% of all cellular proteins are phosphorylated in vivo (Fasolo, et al. 2011). 
Protein phosphorylation is carried out by coupled phosphatases and protein kinases. It is an 
important mechanism that is used for the translation of extracellular signals into cellular 
responses (Jihen, et al. 2011). The phosphorylation generally results in a functional change of 
the target protein by interfering with its cellular location, enzymatic activity and/or 
association with other proteins (Jacob, et al. 2011). 
 
Serine/threonine protein kinases (STPK) have been known to play significant regulatory roles 
in eukaryotes. One of these roles has been described in the Toll signalling pathway in 
Drosophila. As previously described in the Toll signalling pathway; following initial steps in 
the pathway, the intracytoplasmic domain interacts with three proteins which contain the 
serine-threonine kinase domain. This triggers a signal transduction pathway that results in the 
activation of numerous antimicrobial genes (Bulet & Stocklin, 2005; Hancock, et al. 2006).  
 
Cell cycle events are controlled by a family of serine/threonine protein kinases. In addition, 
cell cycle progression is connected to morphogenetic events related to actin organization 
which is controlled by SDA1. SDA1 is among identified proteins in the current study. 
Therefore, these findings are suggestive of a connection between proteins identified in the 
current study.  
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4.4 Conclusion   
 
One of the major aims of the current study was to analyze immune response of SAEIE08 
upon exposure to pathogens, specifically Escherichia coli. Antimicrobial activity upon 
exposure to pathogen was monitored by performing solid and liquid bacterial inhibition 
assays. In liquid growth inhibition assays it was found that treatment with heat-killed E. coli 
induces an immune response in SAEIE08, and that increasing hours of treatment is not 
proportional to induced immune response. Evidence of an immune response was further 
supported by the solid growth inhibition assay, in which clear zone inhibition was observed 
on the LB plate containing a gel run with extracted protein with only a few colonies on the 
outer edges of the gel. Unidentified molecules with sizes of 10 kDa and 16 kDa were 
observed in SDS-PAGE and 2-D PAGE. Some of the molecules were cationic while others 
were anionic or neutral. 
    
Comparison of optical density readings and growth inhibition percentages in this study with 
findings from other studies is rather difficult, since different assay conditions such as liquid 
growth assay vs. plate and different bacterial strains have been used. It is also important to 
take into account that in this study the crude extract (SAEIE08 supernatant) was used for 
growth inhibition assays instead of purified AMPs, therefore, the two are not directly 
comparable because concentrations and identities of peptides in the crude extract are not 
known. Moreover, the crude extract contains additional proteins that may influence 
antimicrobial activity.  
 
Homologues of Saccharomyces cerevisiae proteins that were found in some of the 5′/3′ 
RACE sequences are proteins that play roles in metabolism, cell proliferation and/or 
molecular pathways. These proteins are flavin-containing monooxygenase, fatty acyl-CoA 
synthetase, serine/threonine protein kinase and severe depolymerization of actin protein. It 
remains a challenge to explain how S. cerevisiae protein homologues were found in the E. 
intermedius cell line. Possible explanation could be that short sequences (See appendix 4 on 
page 59) were used for XBLAST searches on the NCBI database. This could have resulted in 
inaccurate matches.  
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In conclusion, this work has shown inducible and constitutive antimicrobial activity in 
embryonic E. intermedius cell line upon exposure to E. coli.  
4.5 Future studies 
 
This study forms the basis for further work on characterization and chemical structural 
analysis of antimicrobial peptides in SAEIE08. The following methods and techniques may 
be employed to achieve the aim to isolate and identify AMPs:  
 
-Mass spectrometric results are expected from the CSIR for identification of high and low 
molecular weight proteins in the current study. Furthermore, the same techniques would 
evaluate the apparent differential protein expression patterns on the treated and untreated cell 
line. 
 
-Analytical techniques such as HPLC would be valuable for further analysis of AMPs in the 
SAEIE08.  
 
-Using more primers from genes that encode antimicrobial peptides and immune-related 
proteins for 5′/3′ RACE and cloning techniques in order to sequence inserts that can match 
existing insect genes that code for AMPs.  
 
-After isolating and identifying AMPs it may be possible to determine the minimum 
inhibition concentration (MIC) for each AMP.  
 
-It is important to work with a variety of pathogens such as Gram-positive and –negative 
bacteria and fungi in order to study the immune response of the SAEIE08 when exposed to 
various pathogens.  
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Chapter 5: Appendices  
 
5.1 Appendix 1  
5.1.1 Materials 
 
Table 5.1: Media 
 
Media Composition/ Supplier 
Grace’s Insect media Highveld  Biological (catalogue # L16) 
Sloppy agar 1% Sodium chloride, 1% Tryptone, 0.5% 
Yeast extract and 0.75% agar 
Solid agar 1 % Sodium chloride, 1 % Tryptone, 0.5 % 
Yeast extract and 1.5 % agar 
Tryptic soy broth  Biolab (Catalogue # HGOOOC16.500) 
 
Table 5.2: Biological buffers and solutions 
 
Buffer/solution Composition/Supplier 
Insect saline 130 mM NaCl, 5 mM KCl, 1 mM CaCl2 
Sodium phosphate buffer Na2HPO4/ NaH2PO4, pH 6.0 
Buffer A 10 mM phosphate buffer, pH 6.0 + 130 mM 
NaCl 
Buffer B Buffer A + 0.2% Bovine serum albumin 
Tri-reagent Sigma-Aldrich (Catalogue # T9424) 
Chloroform Sigma Aldrich (Catalogue # 2432) 
2-propanol Fluka Chemika (Catalogue # 59309) 
75% Ethanol BDH prolabo (Catalogue #20820.327) 
50X TAE electrophoresis buffer pH 8 24.2 w/v % Trisbase 
5.71 v/vv % glacial acetic acid 
3.72 w/v  % Na2EDTA.2H2O 
Buffer I 50 mM glucose 
10 mM EDTA 
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0.25 M TrisHCl pH 8 
Buffer II 1 % SDS 
0.2 N NaoH 
Buffer III 5 M Potassium acetate 
Ethanol : Acetate 25 : 1 
Sodium Dodecyl Sulphate BDH Prolabo (Catalogue # 27926.238) 
TCA Merck (Catalogue # 1026736) 
Acetone ACE (PTY)LTD (Catalogue # 19883/6680) 
Rehydration buffer 8 M urea, 2% CHAPS, 50 mM DTT, 0.2% 
Bio-lyte 3/10 ampholytes 
Biorad protein Assay Bio-Rad (Catalogue # 105463)  
Equilibration buffer I 6 M urea, 2% SDS, 0.375M Tris-HCl pH 
8.8, 20% Glycerol, 2% DTT 
Equilibration buffer II 6 M urea, 2% SDS, 0.375 M Tris-HCl pH 
8.8, 20% Glycerol 
Readystrip IPG strips, pH 4-7 Bio-Rad (Catalogue # 163-2000) 
Electrode wicks, precut Bio-Rad (Catalogue # 1654071) 
Mineral oil Bio-Rad (Catalogue # 163-2105) 
5X SDS running buffer 25 mM Tris, 192 mM Glycine, 1% SDS 
Overlay agarose  0.1% Agarose, 25 mM Tris, 192 mM 
Glycine, 0.1% SDS, trace of bromophenol 
blue 
Running gel 30%Acrylamide/bis-Acrylamide, 
tetramethylethylene (TEMED), 1.5 M Tris 
pH 8.8, 1% SDS, 10%APS 
Coomasie brilliant blue 0.1%Coomasie, 10% Glacial acetic acid, 
40% Methanol 
Coomasie destaining solution 40% Methanol, 10% Glacial acetic acid, 50% 
distilled water 
Silver nitrate solution 
Developer 
 
Destain 
0.1% Ag(NO3)2  
0.1% Formaldehyde 
2% Sodium carbonate 
10% Nitric acid 
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Table 5.3: Living organisms 
 
South African Euoniticellus intermedius 
embryonic cell line (SAEIE08) 
Developed by the Flylab from the School of 
Molecular and Cell Biology at the University 
of the Witwatersrand 
Escherichia coli (strain 1106)  Prof. Jean-Marc Reichhart of the Institut de 
Biologie Moléculaire et Cellululaire, 
Strasbourg, France  
Micrococcus luteus (gus strain) Prof. Jean-Marc Reichhart of the Institut de 
Biologie Moléculaire et Cellululaire, 
Strasbourg, France 
 
Table 5.4: Primers 
 
Primer name Primer sequence 5′→3′ 
Apolllrev reverse primer GAATTCTCATTTGTGGGTTTTATC 
Hop27me reverse primer GTTCGGGTTCTTCACCCCTTTCGTACC 
Defensin reverse primer  TATGACGTAATCTTTGCCGC 
M13 Forward primer GTTTTCCCAGTCACGAC 
M13 Reverse primer CAGGAAACAGCTATGAC 
3′ RACE forward specific primer TGGGCTTGCCCCCA 
 
Table 5.5: Kits and suppliers 
 
Kits  Supplier and catalogue number 
Trizol kit Sigma-Aldrich (Catalogue # T9424) 
 5′/3′ RACE kit, 2nd Generation Roche (Catalogue # 03353621001) 
ReadyPrep 2D-starter kit Bio-Rad (Catalogue # 163-2105) 
High Pure PCR product Purification Kit   Roche (Catalogue # 11732676001) 
pGEM – T Easy vector system Promega (Catalogue # TM042) 
QIAprep Spin Miniprep kit. Qiagen (Catalogue # 27106) 
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Table 5.6: Equipment and machines 
 
Equipment/machines Supplier  
GS800 Calibrated Densitometer Bio-Rad 
UV/Visible Recording Spectrophotometer Shimadzu 
Forced Circulation Incubator Type FSIE Labcon 
MJ Mini personal Thermal Cycler Bio-Rad 
GeneAmp PCR system 2400  Perkin Elmer 
PROTEAN IEF cell Bio-Rad 
Biofuge Pico Heraeus Instruments 
G10 Gyrotory Shaker New Brunswick Scientific 
 
Table 5.7: Software and sequence databases 
 
Software/databases Website/Supplier 
Quantity one version 4.5.2 Bio-Rad (P/N 4000126-16) 
PDQuest 2-D Analysis Software Version 6.2  Bio-Rad (Catalogue #170-9630) 
BLAST http://www.ncbi.nlm.nih.gov/BLAST 
NCBI www.ncbi.nlm.nih.gov 
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5.2 Appendix 2  
5.2.1 pGEM -T Easy Vector 
 
 
 
Figure 5.1: The pGEM – T Easy vector in which PCR products from the 5′ cDNA and 3′ cDNA 
strands were ligated.  
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5.3 Appendix 3  
5.3.1 2-D PAGE gel from TCA precipitated SAEIE08 supernatant.  
  
 
Figure 5.2: 2-D PAGE gel obtained from SAEIE08 supernatant that was concentrated and TCA 
precipitated.
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5.4 Appendix 4 
5.4.1 Short sequences obtained from the 5′/3′ RACE technique 
 
TGCGCAACTGTTGGGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATG 
TGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAAAACGACGGCCAGT 
GAATTGTAATACGACTCACTATAGGGCGAATTGGGCCCGACGTCGCATGCTCCCGGCCGCCATGGCGGCC 
GCGGGAATTCGATTGACCACGCGTATCGATGTCGACGGTGAGTGGGTCACCATGGATAGTGATAAAGAAT 
ATGACGTTGATATGGAAGATAGTGACGATGAAAAAGACAATGCTAAGGGCAAGGAATCAGATTCCGATTT 
GGAACTAAGCGATGATGACGATGAAAAAGAGGTGAAGGATGAGCAAGAAGATACAGATATAGATCCCGAA 
GCTGCCTTCCGTGAAATTGCTTCTACACGTATTTTAACTCCGGCAGATTTCGCTAAACTACAAGAATTGC 
GTAATGAGGAAAGCGTTGCTAAAATAATGGGTATCCACAAACAAGACAAGCGTGAAGAGTTAGTTGATGC 
AAGTACACTAACAGGCCCTATCAAATACAAACAGTCTCGTGAGGAAAGATTACAAAAGGTGTTGGAAGGT 
CGTGAAGGTAGAGACAAATTTGGTAGTAGACGCGGTAAGCGTGACAACATGCGTTCTACTACCAACAGAG 
AAAAAGAAAGAAGGAAGAACTTTGTTATGTCTATTCACAAGAGATCTGTTAGAGGTAAACAAAAAATGTC 
ACTACGAGACAAGCAAAAAGTGTTACGTGCACACATCACTAAAAAAAAAAAAAAGTCGACATCGATACGC 
GTGGTCAATCACTAGTGAATTCGCGGCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGA 
TGCATAGCTTGAGTATTCTATAGTGTCACCTAAATAGCTTGGCGTAATCATGGTCATAGCTGTTTCCTGT 
GTGAAATTGTTATCCGCTCACAATTCCACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGT 
GCCTAATGAGTGAGCTAACTCACATTAATTGCGTTGCGCTCACTGCCCGCTTTCCAGTCGGGAAACCTGT 
CGTG  
Figure 5.3: 5′/3′ RACE sequence that matched to SDA1p. 
 
CGCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTGACACGAMRWATCGATGTCGACTTTTTTT 
TTTTTTTTTGCGAGAAATWACAAGAAGTAACTAGGCATGACAGTGAATGACAAAAAAAGATTGGCAATCA 
TAGGTGGGGGGCCAGGAGGGTTGGCAGCTGCAAGAGTTTTCTCGCAAAGTCTTCCAAATTTTGAAATARA 
AATATTTGTAAAGGATTACGATATTGGCGGTGTCTGGGCATTATCCAGAACAAAAAAGTGATGGGAGGGT 
CATGTATGACCATTTGGAAACCAATATATCAAAGAAGTTAATGCAGTTTAGCGGCTTTCCCTTCGAGGAA 
AACGTCCCTTTATATCCGTCTCGAAGAAACATTTGGGAATACTTGAAAGCCTATTACAAAACGTTCATTG 
CCAATAAAGATGCTGTCAGCATCCATTTCAGCACCGAAGTTACCTACTTAAAGAAGAAGAACTTTCAATG 
GGAGATAACATCTAAAGACGAACTAAGGACTACTAAATCGGATTTTGACTTCGTTATTGTTGCGTCTGGT 
CACTACAGTGTCCCTAAACTACCAACTAATATCGCAGGTCTCGATCTATGGTTCGACAATAAGGGCGCCT 
TTCATTCTAAGGATTTCAAAAACTGCGAGTTTGCCCGTGAAAAAGTCGTTATTGTGGTGGGAAACGGCAG 
TTCCGGCCAAGATATTGCCAACCAACTAACTACCCGTTGCAAAGAAAGTATATAATAGTATAAAAGAGCC 
TGCGAGCAATCAACTGAAGGCCAAGTTAATCGAGACTGTCCAAACAATAGACAGTGCCGATTGGAAAAAT 
CGTTCAGTTACTTTATCTGATGGAAGAGTACTTCAGAATATAGACTACATTATTTTCGCCACAGGCTATT 
ATTACAGCTTTCCATTTATAAAAAAAAAAAAAAAAGTCGAMAWCGATACGCGTGGTCAATCACTAGTGAA 
TTCGCGGCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGATGCATAGCTTGA 
Figure 5.4: 5′/3′ RACE sequence that matched to flavin-containing monooxygenase  
  
CGCATGCTCCCGGCCGCCATGGCGGCCGCGGGAATTCGATTGACYACGCGTATCGATGTCGACTTTTTTT 
TTTTTTTTTCCCGTTTACAKATCTAACGAATATGTTGCTAACATTTGTGTTTATGCCGACCAATCTAARA 
CTAAGCCAGTTGGTATTATTGTACCAAATCATGCTCCATTAACGAAGCTTGCTAAAAAGTTGGGAATTAT 
GGAACAAAAAGACAGTTCAATTAATATCGAAAATTATTTGGAGGATGCAAAATTGATTAAAGCTGTTTAT 
TCTGATYTTTTGAAGACGGGTAAAGACCAAGGTTTGGTTGGCATTGAATTACTAGCAGGCATAGTGTTCT 
TTGACGGCGAATGGACTCCACAAAACGGTTTTGTTACGTCCGCTCAGAAATTGAAAAGAAAAGACATTTT 
GAATGCTGTCAAAGATAAAGTTGACGCCGTTTATAGTTCGTCTTAATGGATCAACATTTCCATGATAGGA 
AAGCCTCATCATACTAAAGCACTTTTTCAGTTTTTTGCTTTAGAACTGCTACCAATTATAAAATAGAATG 
CACAGGTTATCTTGTTTGGTTTGTTATTATCCTTTTTTCTTCTTTACCAGTCATATCACCTCATTCACGT 
ATGTTCGTAATTTATAATAACATGTTAAAAATGGCACAAAAAAAAAAAAAAAAGTCGACATCGATACGCG 
TGGTCAATCACTAGTGAATTCGCGGCCGCCTGCAGGTCGACCATATGGGAGAGCTCCCAACGCGTTGGAT 
GCATAGCTTGA 
Figure 5.5: 5′/3′ RACE sequence that matched to fatty acyl-CoA synthetase  
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